Effect of Arginine and Oscillatory Ca2+ on Vascular Response Mediated Via Nitric Oxide Signaling in Normal and Salt Sensitive Hypertensive Rat Mesenteric Arterioles by Gadkari, Tushar V
Florida International University
FIU Digital Commons
FIU Electronic Theses and Dissertations University Graduate School
2-28-2013
Effect of Arginine and Oscillatory Ca2+ on
Vascular Response Mediated Via Nitric Oxide
Signaling in Normal and Salt Sensitive
Hypertensive Rat Mesenteric Arterioles
Tushar V. Gadkari
tgadk001@fiu.edu
Follow this and additional works at: http://digitalcommons.fiu.edu/etd
Part of the Biomedical Engineering and Bioengineering Commons
This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in
FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact dcc@fiu.edu.
Recommended Citation
Gadkari, Tushar V., "Effect of Arginine and Oscillatory Ca2+ on Vascular Response Mediated Via Nitric Oxide Signaling in Normal
and Salt Sensitive Hypertensive Rat Mesenteric Arterioles" (2013). FIU Electronic Theses and Dissertations. Paper 891.
http://digitalcommons.fiu.edu/etd/891
FLORIDA INTERNATIONAL UNIVERSITY 
Miami, Florida 
 
 
EFFECT OF ARGININE AND OSCILLATORY Ca2+ ON VASCULAR RESPONSE 
MEDIATED VIA NITRIC OXIDE SIGNALING IN NORMAL AND SALT 
SENSITIVE HYPERTENSIVE RAT MESENTERIC ARTERIOLES 
 
 
 
 
A dissertation submitted in partial fulfillment of 
the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
in 
BIOMEDICAL ENGINEERING 
by 
Tushar V. Gadkari 
 
 
2013 
 
 
ii 
 
To:  Dean Amir Mirmiran 
 College of Engineering and Computing 
 
This dissertation, written by Tushar V. Gadkari, and entitled Effect of Arginine and 
Oscillatory Ca2+ on Vascular Response mediated via Nitric Oxide Signaling in Normal 
and Salt Sensitive Hypertensive Rat Mesenteric Arterioles, having been approved in 
respect to style and intellectual content, is referred to you for judgment. 
 
We have read this dissertation and recommend that it be approved. 
 
 
_______________________________________ 
Chenzhong Li 
 
_______________________________________ 
Yen-Chih Huang 
 
_______________________________________ 
Konstantinos Kavallieratos 
 
_______________________________________ 
Nikolaos Tsoukias, Major Professor 
 
 
Date of Defense: February 28, 2013. 
The dissertation of Tushar V. Gadkari is approved. 
 
_______________________________________ 
Dean Amir Mirmiran 
College of Engineering and Computing 
 
 
_______________________________________ 
Dean Lakshmi N. Reddi 
University Graduate School 
 
 
 
 
Florida International University, 2013 
 
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright 2013 by Tushar V. Gadkari 
 
All rights reserved. 
 
 
 
 
 
 
 
 
 
iv 
 
DEDICATION 
 
गुरुबर्र्ᳬागुरुिवष्णुःगुरुदᱷवोमह᳡ेरः। 
गुरुरेवपरंबर्ᳬतस्मैशर्ीगुरवेनमः॥ 
 
 ‘Salutation to the noble Guru, who is Brahma, Vishnu and Maheswara, the Parabrahma, 
the Supreme Reality.’ 
 
 
 
 
 
 
To my parents, Snehal Vijay Gadkari and Vijay Mahadev Gadkari 
In memory of my beloved ‘amma’ 
 
 
 
 
 
v 
 
ACKNOWLEDGMENTS 
     I would like to extend my sincere appreciation to Dr. Nikolaos Tsoukias for being 
such a great mentor. His patient yet persistent guidance has taught me to never give up on 
my goals and the value of critical thinking. He is a big part of the success of this 
dissertation and all my future accomplishments. 
     I would like to thank Dr. Joshi and Dr. Kapela for their patience and encouragement 
through every mistake I made during the learning process. 
     I would like thank all my committee members Dr. Chenzhong Li, Dr Yen-Chih Huang 
and Dr. Konstantinos Kavallieratos who have provided advice and invaluable insight 
towards my dissertation. 
     I gratefully acknowledge the financial support of the Florida International University, 
the Dissertation Year Fellowship and the National Institute of Health for funding my 
research projects. 
     I want to thank my lab members and my roommates who stood by me through 
difficult times and helped me accomplish my goals. 
     Finally, the blessings my Amma, Mummy, Baba, Sanju Kaka, Kaki, Nanda Mama, 
Mami,  Vaibhav Dada and the love of Trupti and Saurabh has made this dream a reality. 
 
 
 
 
 
 
vi 
 
ABSTRACT OF THE DISSERTATION 
EFFECT OF ARGININE AND OSCILLATORY Ca2+ ON VASCULAR RESPONSE 
MEDIATED VIA NITRIC OXIDE SIGNALING IN NORMAL AND SALT 
SENSITIVE HYPERTENSIVE RAT MESENTERIC ARTERIOLES 
by 
Tushar V. Gadkari 
Florida International University, 2013 
Miami, Florida 
Professor Nikolaos Tsoukias, Major Professor 
     Hypertension, a major risk factor in the cardiovascular system, is characterized by an 
increase in the arterial blood pressure. High dietary sodium is linked to multiple 
cardiovascular disorders including hypertension. Salt sensitivity, a measure of how the 
blood pressure responds to salt intake is observed in more than 50% of the hypertension 
cases. Nitric Oxide (NO), as an endogenous vasodilator serves many important biological 
roles in the cardiovascular physiology including blood pressure regulation. The 
physiological concentrations for NO bioactivity are reported to be in 0-500 nM range. 
Notably, the vascular response to NO is highly regulated within a small concentration 
spectrum. Hence, much uncertainty surrounds how NO modulates diverse signaling 
mechanisms to initiate vascular relaxation and alleviate hypertension.  
     Regulating the availability of NO in the vasculature has demonstrated vasoprotective 
effects. In addition, modulating the NO release by different means has proved to restore 
endothelial function. In this study we addressed parameters that regulated NO release in 
the vasculature, in physiology and pathophysiology such as salt sensitive hypertension. 
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We showed that, in the rat mesenteric arterioles, Ca2+ induced rapid relaxation (time 
constants 20.8 ± 2.2 sec) followed with a much slower constriction after subsequent 
removal of the stimulus (time constants 104.8 ± 10.0 sec). An interesting observation was 
that a fourfold increase in the Ca2+ frequency improved the efficacy of arteriolar 
relaxation by 61.1%. Our results suggested that, Ca2+ frequency-dependent transient 
release of NO from the endothelium carried encoded information; which could be 
translated into different steady state vascular tone. Further, Agmatine, a metabolite of L-
arginine, as a ligand, was observed to relax the mesenteric arterioles. These relaxations 
were NO-dependent and occurred via α-2 receptor activity. The observed potency of 
agmatine (EC50, 138.7 ± 12.1 µM; n=22), was 40 fold higher than L-arginine itself (EC50, 
18.3 ± 1.3 mM; n = 5). This suggested us to propose alternative parallel mechanism for 
L-arginine mediated vascular relaxation via arginine decarboxylase activity. In addition, 
the biomechanics of rat mesentery is important in regulation of vascular tone. We 
developed 2D finite element models that described the vascular mechanics of rat 
mesentery. With an inverse estimation approach, we identified the elasticity parameters 
characterizing alterations in normotensive and hypertensive Dahl rats.   
     Our efforts were towards guiding current studies that optimized cardiovascular 
intervention and assisted in the development of new therapeutic strategies. These 
observations may have significant implications towards alternatives to present methods 
for NO delivery as a therapeutic target. Our work shall prove to be beneficial in assisting 
the delivery of NO in the vasculature thus minimizing the cardiovascular risk in handling 
abnormalities, such as hypertension. 
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CHAPTER 1 
Introduction 
1.1 Motivation 
Hypertension has shown to play a significant role in triggering substantial health 
problems and targeting multiple end organs, thus leading to complex pathologies. Many 
factors, such as neuronal stimulus, hormonal release, cell signaling mechanisms and 
protein-protein interactions interplay together and make it difficult to isolate the precise 
cause of hypertension. Its pathogenesis thus remains intriguingly unknown.  
Salt sensitivity is a measure of how the blood pressure responds to salt intake [1]. Salt 
sensitivity is observed in 50% of the hypertension cases [2]. High dietary sodium has 
been linked to multiple cardiovascular disorders including hypertension. Extensive 
literature and experimental data  has been put forward to elucidate the mechanism of salt-
sensitive hypertension [3]. However, there still exists only a vague understanding of how 
salt intake alters blood pressure regulation and causes hypertension.  
Nitric Oxide (NO), after being identified as an endothelium derived relaxing factor 
(EDRF) [4], has garnered widespread attention as an endogenous vasodilator [5; 6; 7] and 
a putative neurotransmitter [8]. NO participates as an effector molecule in diverse and 
complex signaling mechanisms at various molecular levels. It serves many important 
biological roles in the cardiovascular physiology including blood pressure regulation. 
Recent studies trying the decipher the roots of hypertension have aroused significant 
interest in understanding  mechanisms behind the L-arginine-Nitric Oxide system [9; 10; 
11; 12] and pressure-volume regulation [13]. Substantial studies have reported decreased 
levels of NO production, reduced bioavailability or impaired cellular effects of NO in 
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hypertension leading to elevated arterial pressure. The widely accepted mechanism of NO 
action via the L-arginine-eNOS-NO-sGC-cGMP pathway is impaired at different levels 
[14; 15; 16], causing either enhanced vasoconstriction or suppressed vasodilatory effects. 
Vascular dysfunction is generally observed with the role of endothelium severely 
compromised in human as well as animal models [17; 18; 19]. There is a broad 
understanding about the underlying mechanisms involved in hypertension, however, the 
opinions seem to vary [23]. Few researchers have indicated increased NO levels, 
suggesting feedback mechanisms responding to hypertension [24; 25; 26; 27]. However, 
there is a general agreement with NO-mediated activity being significantly disrupted 
under hypertensive conditions. 
     NO is primarily synthesized in the vasculature by the oxidation of L-arginine to L-
citrulline in the presence of O2, NADPH and BH4 in a NOS catalysed reaction. Vascular 
endothelium has shown to play an important physiological role in the dynamics of 
circulation [28]. Several theories [29; 30; 31; 32] have been proposed to elucidate the 
possible mechanism of NO induced vascular smooth muscle relaxation. A general 
consensus agrees towards NO produced in the endothelium under agonist stimulus; 
diffuses to the smooth muscle where it binds with high affinity to the ferrous heme of 
sGC to form a five coordinate Fe2+-NO complex. This heme containing compound 
facilitates the catalytic conversion of GTP to cGMP leading to downstream 
phosphorylation of secondary messenger molecules and signal transduction. Modulation 
of calcium homeostasis plays an integral role in the downstream effect such as 
phospholipase C activity leading to the production of diacylglycerol (DAG) and inositol 
1,4,5-triphosphate (IP3) which triggers the activation of IP3 receptors leading to increase 
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in intracellular calcium concentration modulated through the activity of ion channels. The 
NOS isoform expressed in the endothelial cells (eNOS), synthesizes majority of the NO 
produced in the vasculature [33; 34]. The eNOS, localized in the calveole [35] is inactive 
at the resting intracellular calcium levels, however under agonist stimulus, the 
intracellular calcium levels increase to facilitate complex protein-protein interactions [36] 
leading to calveolin-1 dissociation [33; 35], calmodulin binding and enzyme activation by 
phosphorylation [37; 38; 39]. When the intracellular calcium subsides and returns to 
basal levels it reverses the cycle to inactivate the eNOS. Several other mechanisms [37; 
40] may stimulate the eNOS with transient increases in the intracellular calcium level 
playing an important role in regulating eNOS activity. The activation of eNOS has been 
reported in response to shear stress and under pulsatile conditions [41; 42].  
 
Fig 1.1 Mechanism of nitric oxide action to induce vascular relaxation 
     The arterioles demonstrate ability to control the vasomotor tone by modulating the 
vascular resistance. Increased sympathetic nerve activity is indicated to play a role in 
elevating vascular resistance in response to pulsatile circulation [43]. The kinetics of NO-
cGMP pathway resembles a neuro-transmission mechanism, in which NO as a neuro-
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modulator  regulates vascular tone by activation of sGC causing cGMP accumulation 
[44]. Even though the mechanisms of sGC activation and deactivation are not clearly 
understood, it is observed that exposure to NO amplifies the sGC activity several hundred 
fold [45]. It is suggested that the NO binding to sGC acts as a physiological switch, 
where the binding of NO and the breaking of the His-Fe2+ bond is the first molecular 
event in progression of catalytic activation of sGC. In the smooth muscle, two temporally 
distinct states of sGC activation have been identified [46]. Initial basal levels of NO 
partially activates the sGC, leading to a formation of stable NO-Fe2+ complex, which 
produces low basal levels of cGMP to modulate the resting state vascular tone. A further 
acute increase in the NO availability follows a transient fully active enzyme which 
triggers increased cGMP production to facilitate phosphorylation of downstream targets 
leading to signal transduction and vascular relaxation [47; 48]. In addition, the 
desensitization of sGC is reported to cause transient and plateau patterns of cGMP 
responses which might play a role in selection of a particular cGMP mediated 
downstream signal transduction pathways [49; 50]. Under rapid dynamics the cGMP 
formation can be correlated to NO. The properties of sGC were observed to be different 
in cells and under purified condition [49]. Various binding rates of NO to sGC have been 
reported to provide a comprehensive NO-sGC binding kinetic analysis broadly 
suggesting rapid activation of sGC, typically few seconds following a much slower 
deactivation typically a couple of minutes [51; 52].  
1.2 Frequency-Dependent Regulation of Vascular Tone 
     EDRF release has been reported to be modulated both by frequency and amplitude of 
the agonist activity such as flow, receptor binding or ion channel operation [53; 54]. 
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There is a possibility that NO produced under such an influence may demonstrate 
oscillatory behavior in vivo. In response to the vasoactive stimulus, tonic oscillations of 
the diameter are observed in isolated arterioles [55]. The intracellular calcium is observed 
to follow a wave like pattern [56]. Under basal conditions, temporally coupled transient 
elevations of intracellular calcium are observed in vascular smooth muscle cells [57]. 
These synchronized calcium oscillations are regulated by endothelium derived NO. 
Oscillatory changes in blood pressure and flow have widely been correlated with the 
arteriolar tone regulation. Intracellular calcium is shown to play a crucial role is 
modulating the vascular tone. Vascular pulsations have shown beneficial cardiovascular 
effects which is linked to NO activity [58; 59].  
     NO availability is compromised in presence of several reactive oxygen species [60; 
61]. This is accelerated even further with presence of hemeproteins in the surrounding 
vicinity of NO production site. Even though alternative roles of heme proteins as 
transporter of nitric oxide have been suggested [62; 63], oxy-hemoglobin is suggested to 
be the primary scavenger for nitric oxide from the biological systems [64; 65]. Palmer 
et.al  showed that NO stimulated relaxation contracted back to basal state with a half life 
of 1-2 min and suggested the deactivation may be occurring by dissociation of NO from 
sGC [66]. Since then, various dissociation constants of NO from nitrosyl complexes of 
hemeproteins ranging from 1×10-3 to 1.8×10-5 sec-1 have been reported. Kharitonov [67; 
68] measured the rate constant for NO-sGC dissociation of around 6×10-4 sec-1 at 20ºC 
which translates to a half life of about 2 min. Brandish et al [69] suggested that with the 
use of oxy-hemoglobin as a trap for NO, the rate constant for reversal for NO-sGC to 
ferrous sGC was 0.28 min-1 or a half life of  2.5 min at 37ºC. Studies have as well 
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suggested much faster dissociation rates [70] and a correlation to the acceleration of NO-
sGC dissociation with the availability of substrates [69; 71]. In consensus, an overall 
understanding is that the sGC activation half life is relatively fast atleast an order faster in 
magnitude than its deactivation.  
    A twostate release of NO is possible with a sustained basal NO available which 
maintains steady vaso-dynamic tone and an oscillatory NO which occurs in burst to 
mimic the intracellular calcium bursting. It is likely that information is being transmitted 
from the endothelium to the smooth muscle in two states, a basal state facilitating a 
steady tone, and activated state triggering acute relaxation responses. Time-dependent 
NO release characteristics might play crucial role in facilitating such an activity.                                        
   In chapter 2, we tested the hypothesis previously proposed in our earlier work [72], 
experimentally by designing in-vitro experiments on isolated, cannulated and pressurized 
rat mesenteric arterioles. We demonstrated that a frequency-dependent delivery of nitric 
oxide achieved by modulating the NO bursting period could be a more effective way to 
deliver NO mediated drugs. We observed that a transient delivery of NO created by 
varying the NO pulse duration d over the period T exhibited a temporally dependent 
summation effect in achieving steady diameter tone. The observed steady states in 
diameter indicate a possibility that NO might escape scavenging if delivered in quick 
burst. A faster activation and slower deactivation of vessel might suggest a possible build 
up of NO activity. Since different mechanisms govern the production and consumption of 
NO, frequencies of burst fast enough to activate sGC might lead to a variable rate of NO 
accumulation in the vasculature. The pharmacological effects of such delivery may 
possibly perturb an intact signal transduction pathway. 
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   Various NO donating drugs are being used with a wide range of clinical concentrations 
for regulating the tonic machinery in the vasculature [73]. Such drugs target the 
hemodynamic variables such as agonist activity, pulsatile flow, shear stress which 
facilitate oscillatory calcium release [74; 75]. These vasoactive agents control the 
vascular reactivity to achieve hemodynamic stability. However the potency of such drugs 
is compromised as they simultaneously influence a variety of other cellular and molecular 
mechanisms initiating non-specific actions. For NO based therapies to be effective in a 
wide range of applications, optimizing the efficiency of NO trapping and devising 
alternative methods of NO delivery are desirable. In this study, we illustrated the 
possibility that the frequency of NO bursting may have encoded information regarding 
vessel tone regulation. Design of drugs that incorporate the time period of NO release by 
modulating the frequency of NO bursts to regulate the endogenous NO bioavailability 
might provide a novel therapeutic technique for delivering NO in a more potent and 
efficient manner.  
1.3 Agmatine as a mediator of L-arginine induced relaxations 
     L-arginine, a precursor to nitric oxide has shown to play an important physiological 
role in regulating the endogenous NO levels. L-arginine is required for optimal NO 
synthesis by nitric oxide synthase (NOS) in the rat mesenteric artery [76]. The 
importance of L-arginine as a therapeutic element in various physiological and 
pathophysiological processes such as wound healing [77; 78], protein synthesis and 
muscle building [79], endocrine metabolism [80], erectile dysfunction [81], 
cardiovascular functions [82; 83; 84] has widely been reported. It is suggested that L-
arginine acts as a substrate for NOS to facilitate NO production [85]. The reported Km 
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values for NOS isozymes range in 2-20 µM [85], particularly for eNOS it is reported to 
be 2.9 µM [86]  and the intracellular L-arginine levels are in the range of 0.8 – 2 mM[87]. 
This would suggest that these enzymes are saturated with the substrate however it is 
observed that the rate of NO production varies with extracellular L-arginine 
concentrations [88; 89; 90]. If exogenous L-arginine acts as substrate and is present in 
saturating concentrations there should be a continuous production of NO. This 
discrepancy is widely referred to as L-arginine paradox [84]. There have been various 
mechanisms hypothesized to explain this behavior [91; 92; 93; 94] however there still 
exists an ambiguity in understanding how L-arginine mediates NO dependant relaxation. 
In addition to the beneficial effects of exogeneous arginine, recent study has 
demonstrated a possible role of agmatine as a potential vasodilator substance [95].  
     Agmatine [4-(aminobutyl) guanidine], a decarboxylation product of L-arginine, is 
produced endogenously under the activity of enzyme arginine decarboxylase (ADC) [85]. 
The importance of agmatine has been highlighted with its discovery as a novel 
neurotransmitter [96; 97] demonstrating its potential to affect multiple biological targets 
[98]. Various neuroprotective roles of agmatine [99], such as its role as a potential 
analgesic [100; 101] due to its effect of on NMDA receptor [97] or as a biphasic opoid 
function modulator [100] have been put forward. Agmatine has shown to reverse pain 
induced by inflammation [99] and provide protection to retinal ganglion cells from 
hypoxia [102]. The presence of agmatine in serum [103] suggested a physiological role 
for agmatine in the vasculature. The endothelial cells have shown to express ADC 
activity [104] and it has been reported that agmatine activates NOS in endothelial cells 
[105]. Further, agmatine shares its properties with clonidine-displacing substance [106] 
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and consist of a guanidium group which creates a  possibility of agmatine binding as a 
ligand to imidazoline and α-2 type adrenergic receptors [96; 98; 104; 106; 107; 108]. In 
previously published data [89] we showed that L-arginine or one of its decomposition 
product may be initiating the NO synthesis via receptor binding and release of 
intracellular Ca2+ in endothelial cells. 
     In chapter 3, we presented a novel mechanism, where agmatine produced in the rat 
mesentery by the decomposition of L-arginine in presence of ADC activity initiates 
vascular relaxation. We showed that agmatine binding as a ligand on α-2 type adrenergic 
receptor and mediating relaxation via NO activity. To demonstrate this, we investigated 
the possible role of agmatine as a ligand, by performing reactivity study with 
intraluminally perfused exogenous agmatine and arginine. We further investigated the 
contribution of agmatine activity in hypertension. 
1.4 Biomechanical properties of rat mesenteric arterioles 
     Mesenteric arterioles are referred to as resistance vessel as they contribute 
significantly to increased vascular resistance leading to blood pressure regulation [109]. 
The vascular tone and regional blood flow in the microcirculation depend on passive 
biomechanical properties of the vessel wall and on active constrictions of the vascular 
smooth muscle cells (SMC). The contractile state of SMCs depends on the intracellular 
calcium (Ca2+) concentration and is regulated by an elaborate network of signaling 
pathways. In hypertension, complex remodeling of the vasculature with altered structure 
and mechanics of the resistance arteries is observed [110; 111; 112]. Several factors have 
been shown to play a role in vascular remodeling leading to morphological and functional 
changes in the vasculature [113; 114].   
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     In chapter 4, we estimated the mechanical parameters of the rat mesenteric arterioles. 
We characterized the morphological differences in normotensive and hypertensive 
conditions. The pressure-diameter and pressure-thickness relationships play an important 
role in establishing normal blood flow conditions in the vasculature. Our understanding 
of physiological behavior at the tissue level in normotensive and hypertensive conditions 
is facilitated by obtaining pressure elongation relationships under isometric conditions. 
The compliance of the vasculature i.e. the slope of the pressure-diameter relationship is 
important in determining the non-linearity associated with the pressure flow relationship. 
The strain is computed from the changes in the circumferential and longitudinal 
displacement measurements relative to the zero stress state. We developed mathematical 
model to integrate the pressure-strain relationships obtained from the experiments.  
Inverse modeling approach enabled us to estimate the material properties such as the 
elasticity coefficients associated with the rat mesenteric vessels under normotensive and 
hypertensive conditions. This provided us a valuable insight in the abnormalities 
occurring in the mechanical structure of the vessel under both physiological and 
pathophysiological conditions. Our computational models further assisted in parameter 
estimation to characterize vascular properties and provided correlation between the 
different study groups.  
1.5 Vascular reactivity study with Dahl salt sensitive hypertension model 
     The Dahl salt sensitive rat is a rodent model of hypertension that exhibits many 
phenotypic traits common with hypertensive disease observed in human populations 
[115]. Similarities include sodium sensitivity of hypertension and reduced renal function 
[116], elevated urinary excretion of protein and albumin, and a low plasma renin activity 
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[117], tubulointerstitial injury and the loss of nitric oxide synthase (NOS) in the 
development of hypertension [118]. It is suggested that the structural and functional 
changes that occur with vascular injury in the Dahl salt sensitive rat may contribute to the 
development of hypertension [18]. It is widely accepted that NO plays an important role 
in hypertension [8]. NO-mediated relaxation is observed to be impaired in salt sensitive 
hypertension [119]. Understanding the NO related mechanism in hypertension is crucial 
in alleviating high blood pressure related problems and designing more efficient drugs.  
     In chapter 5, we investigated the contribution of EDRF, EDHF and α-2 receptor 
mediated activity in salt sensitive hypertension. We tested the vascular responses of rat 
mesenteric arterioles in high salt (4% NaCl) and low salt (0.49% NaCl) fed Dahl salt 
sensitive rats. Our observations confirmed the possibility of multiple parallel Ca2+-
dependent and independent pathways influencing NO induced relaxation responses.   
1.6 Summary 
In summary, the goal of this study was to contribute towards the understanding of NO 
mediated vascular tone regulation and its implications towards blood pressure regulation 
in physiological and pathological condition of salt sensitive hypertension.   
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CHAPTER 2 
Frequency-dependent effect of Ca2+ induced nitric oxide release on the regulation of 
vascular tone in rat mesenteric arterioles 
2.1 Introduction 
     Nitric Oxide (NO) as an endogenous vasodilator [5; 66] has been shown to participate 
in complex signaling mechanisms between endothelial cells (EC) and smooth muscle 
cells (SMC).NO produced in the endothelium diffuses to the smooth muscle where it 
modulates Ca2+ levels to induce smooth muscle relaxation. The NOS isoform, eNOS 
expressed in the endothelial cells, synthesizes majority of the NO produced in the 
vasculature [33]. 
     Even though the biological role of NO and its mechanism of action are broadly 
established, the physiological concentration at which NO activates various signaling 
cascades is yet to be delineated. A wide range between picomolar to nanomolar may be 
regulating the tonic machinery in the vasculature [120; 121]. Recent developments have 
vaguely pointed the endogenous NO concentrations to range between 100 pM to 5 nM 
[121]. Notably, the sensitivity of the vascular response to NO is highly regulated in a 
small concentration spectrum. Thus, how NO initiates vascular responses in multiple 
pathways has remained an intriguing question.    
     Ca2+ is involved in the simultaneous regulation of many cellular processes [56; 122]. 
Several experiments have suggested Ca2+ oscillations to play a role in mediating 
concurrent signal transduction in different signaling cascades. Signaling between 
intracellular Ca2+ stores and Ca2+ channels have shown to generate intracellular 
Ca2+oscillations in T lymphocytes [123]. Diverse cell functions are regulated by 
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information transmitted in the amplitude, duration or frequency of such oscillations 
[124]. Enzyme CaMKII has demonstrated the capability to decode the frequency of 
calcium oscillation into specific amount of kinase activity [125]. Konick et al [126] 
showed that three splice variants of β-CaMKII had different specific activity to Ca2+ 
oscillations and suggested that alternative splicing provided cells a mechanism to 
modulate their sensitivity to Ca2+ oscillations. Dolmetsch et.al [127] showed that the 
specificity towards a gene expression is modulated by the frequency of calcium 
oscillation. RasGTPases are binary switches that regulate Ras are likely to act as one of 
the decoder for information processing of Ca2+ Oscillation [128]. Ca2+ oscillations have 
shown to optimize Ca2+ mediated activation of Ras/ERK/MAPK pathway and facilitate 
its efficient activation [129]. CaMKII-PP1 exhibited switch like, all or none potentiation 
of individual hippocampal synapse in response to transient Ca2+ elevation [130].  
     In addition, the magnitude of contractile activity of the smooth muscle cells were 
determined by the frequency of calcium oscillations in rat intrapulmory arterioles [131], 
[132]. In the glia, intracellular Ca2+ facilitated intracellular IP3 production, which 
resolved the information provided by a local Ca2+ wave into distinct spatial and temporal 
pattern of Ca2+ oscillation [133]. NO has been shown to induce smooth muscle cell 
relaxation by photolytic release of IP3 with a decrease in the frequency of Ca2+ 
oscillations [134]. The eNOS may be one of the enzymes regulated by transient increases 
in calcium level [135]. NO produced under such influence may demonstrate oscillatory 
behavior in vivo.  
     Other theoretical studies [136; 137; 138; 139], have supported similar argument 
suggesting frequency of Ca2+ oscillations to transmit signaling information to regulate 
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cellular activity. Using nonlinear transformations [140], showed that biological processes 
with different time constants responded preferentially to different temporal stimuli. 
Selective regulation of different proteins was modeled by changes in bursting patterns of 
Ca2+ oscillation [137]. Empirical models have demonstrated sensitivity of enzymes such 
as CaMKII to optimal frequencies of Ca2+ oscillation [141]. Models for the kinetic 
activity of liver glycogen phosphorylase predicted Ca2+ oscillation frequency to reduce 
the threshold for enzyme activation [142].  Even though these studies made sound 
predictions, majority of them lacked experimental validation.  
     In our previous theoretical work, [72] has suggested that under certain conditions, 
transient release of NO may control the enzymatic activation of sGC. We demonstrated 
theoretically, a possible role for frequency-dependent control of cGMP formation under 
the influence of transient NO. A burst like production of NO may be observed after 
endothelial activation in response to periodic bursts of intracellular free Ca2+ [143]. The 
frequency of NO burst arising from the frequency of calcium oscillations in the EC may 
regulate cGMP formation in the SMC and control the vascular tone. We thus proposed 
oscillatory nature to NO activity that resulted from interaction between endothelial Ca2+ 
transients and eNOS.  
      In this study, we tested the vascular responses to Ca2+ frequency induced NO release. 
In-vitro experiments were performed on isolated, perfused rat resistance arterioles. We 
introduced oscillatory behaviour in the arterioles by modulating the pulse width of 
induced Ca2+ delivery. This could be translated to summation responses that were 
observed in the arteriolar tone. We showed that, frequency-dependent Ca2+ induced NO 
release may have encoded information that can be correlated to arteriolar tone.  
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2.2 Materials and Methods 
2.2.1 Isolated Vessel Preparation 
Experiments were performed on second order mesenteric arterioles (external 
diameter 360 ± 30 µm) isolated from male Sprague-Dwaley rats (250-300 g). The 
arterioles were cleaned of the surrounding tissue and cannulated with sutures on glass 
cannulas in a cannulation chamber. The preparation was placed in a perfusion bath 
maintained at 22°C and superfused with modified Krebs-Ringer buffer solution. The 
buffer solution (to ensure a pH of 7.4) was composed of the following (in mM): NaCl 
145, KCl 5, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, HEPES 20, and Glucose 10.1. The 
arterioles were pressurized to a constant pressure of 50 mmHg and stretched 
longitudinally to simulate physiological stretch condition. Only arterioles without leaks 
were used. Any arteriole that did not fully contract or fully relax was discarded. The 
preparation was allowed to equilibrate for 60 min before experimentation. Throughout 
the experiment, the tissue bath was continuously circulated with norepinephrine (2 µM) 
using a peristaltic pump. When steady constriction was established vascular reactivity 
was examined by intraluminal injection of solutions with an automated pressure driven 
system. A fast switching perfusion pencil allowed instantaneous exchange between 
different solutions (dead volume < 165 µl). Changes in the arteriolar diameter were 
recorded in real time on the stage of an inverted microscope (IX81, Olympus), fitted with 
a CCD video camera (1350B, QImagingRetiga) for data acquisition. The Image 
acquisition and post analysis of data was performed with IPLAB (BioVision 
Technologies) and MATLAB (MathWorks) software. The diameter at resting state was 
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taken as 0% relaxation obtained during precontraction to norepinephrine (2 µM). The 
vascular relaxation was expressed as percent increase in the resting diameter.  
 
Fig 2.1. Schematic representation of the vascular reactivity methodology 
2.2.2 Intraluminal loading of endothelium with fura 2-AM 
To observe induced Ca2+ responses from the endothelium of intact arterioles, we 
loaded the pressurized mesenteric arteries with the ratiometeric Ca2+-sensitive fluorescent 
dye fura 2-acetoxymethyl ester [144]. Fura 2-AM was dissolved in anhydrous DMSO at a 
concentration of 1 mM. Prior to loading, fura 2-AM was mixed with 10% solution of 
Pluronic F127 in DMSO. This solution was diluted with modified Krebs-Ringer buffer to 
yield a final concentration of 5 µM fura 2-AM and 0.05% Pluronic acid. Solenoid valve 
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operated perfusion system facilitated selective endothelial loading after delivery of fura 
2-AM into the lumen for 5 min. This was followed by a 20 min washout with buffer 
solution to remove residual fura 2-AM from the lumen. After washout endothelial 
loading was visible on the luminal side of the artery in the focal plane. Similar loading 
protocols have previously shown that subsequent measurements are from endothelial 
Ca2+ with negligible contribution from smooth muscle [145; 146]. We assessed the 
changes in induced intracellular Ca2+ by calculating the ratio of the light emitted through 
a 510 nm emission filter when the vessel was illuminated at 340 and 380 nm respectively. 
2.2.3 Materials 
Fura 2-AM and Pluronic F127 were purchased from Molecular Probes (Eugene, 
OR). All other salts and drugs used in the study were purchased from Sigma, (St. Louis, 
MO). Male Sprague-Dwaley rats were obtained from Harlan Laboratories, (Madison, WI) 
and were maintained on standard pellet chow diet (2018 Teklad Global). All animal 
procedures were carried out in accordance with the National Institute of Health guidelines 
and were approved by the institutional animal care and use committee of florida 
international university.  
2.2.4 Data analysis 
Unless otherwise stated, all values are given as mean ± SE, n = number of rats. 
Results were presented as the normalized diameter (i.e, diameter divided by the fully 
relaxed diameter for the experiment). EC50 values were calculated by fitting 
concentration-response relationships to a sigmoidal curve. Statistical analysis was 
performed using student’s t test. A P value < 0.05 was considered statistically significant.  
18 
 
2.2.4 Mathematical model 
To assist our experimentation, we simulated the effect of frequency-dependent 
Ca2+ activity on diameter changes. We assumed the Ca2+ changes to induce diameter 
responses following a monoexponential relationship.  The Ca2+ changes were modeled as 
a train of pulses described by a piecewise constant function  
( )


=
0
0QtQ ( )TitdiT
diTtiT
1+<≤+
+<≤
;     ∞= ....,,0i             2.1 
characterized by period T, amplitude Q, and pulse duration d. The diameter response to 
Ca2+ resulted in vascular activation to the rising pulse ( )diTtiT +<≤ given by   
( ) ( )[ ]( ) ( )iTDeiTDDtD dtkdassa a +−−= −1., ,                         2.2 
followed by vascular deactivation when the pulse subsides ( )( )TitdiT 1+<≤+ given by  
( ) ( )[ ] ( )( )( ) ( )diTDediTDDtD adiTtkadssd d ++−+−= +−−1., ,                               2.3 
wherea represents the activation cycle, d describes the deactivation cycle and steady 
states were denoted by assD , and dssD , respectively. The reaction rates, ( ) relaxationak τ/2ln=
and ( ) onconstrictidk τ/2ln= were calculated from time constants for the mesenteric arterioles 
obtained in our experiments.  
2.3 Results 
2.3.1 NO-mediated vascular activity 
     To establish a preconstriction concentration that gave submaximal constriction, we 
constructed a dose response curve to norepinephrine (Fig 2.2A). The EC50 value observed 
for norepinephrine was 0.3 ± 0.1 µM, n = 3. Steady constriction were retained at 2 µM, 
norepinephrine. In Fig 2.2B, intraluminally injected Acetylcholine [1 nM – 10 µM] 
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produced dose-dependent relaxation in arterioles from the resting state. Acetylcholine 
relaxed the arterioles with EC50 value of 130.8 ± 0.7 nM, n = 6. The sensitivity to 
acetylcholine significantly decreased following treatment with L-NAME (0.5 mM), an 
eNOS blocker, n = 5. After eNOS blockade, maximum relaxation to acetylcholine 
attenuated from 92.8 ± 1.5% to 37.5 ± 5.1% demonstrating contribution of NO towards 
relaxation.  
 
Fig 2.2. Concentration dependent relaxation responses to norepinephrine and Ach. 
(A). Dose-response to intraluminal perfusion of norepinephrine, NE (●, 1nM-10µM, 
n = 3) in Sprague Dwaley rat resistance arterioles. (B). Concentration dependent 
dose response curve to intraluminal perfusion of Acetylcholine, Ach (●, 1nM-10µM) 
in rat resistance arterioles, n = 6, along with response after inhibition with NG-
nitro-L-arginine methyl ester, L-NAME (■), an eNOS blocker (0.5 mM), n = 5, 
demonstrating the role of nitric oxide in endothelium dependent relaxation. Inset 
shows arterioles constricted to 2µM NE and fully relaxed to 10µM Ach. All data are 
presented as mean ± SEM. 
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2.3.2 Time constants for rat resistance arterioles 
To obtain time constants for Ca2+ induced vascular responses, we subjected the 
arterioles to intraluminal Ca2+ influx with A23187 (10 µM) and subsequent removal of 
Ca2+ with EGTA (500 µM) solution. In Fig 2.3 (A), we showed the vascular response to 
Ca2+ influx triggered with A23187 along with the response after eNOS blockade with L-
NAME (0.5mM). In Fig 2.3 (B), we demonstrated the contribution of EDRF to relaxation 
by blocking the EDHF component with apamine (50 nM) and tram-34 (100 nM). 
Complete inhibition of relaxation was observed following a treatment with a combination 
of EDHF and EDRF blockers (apamine (50 nM), tram-34 (100 nM) and L-NAME 
(0.5mM)). The calculated time constants for these vascular responses as shown in Fig 2.3 
(C-E), were τrelaxation = 20.8 ± 2.2 sec, n = 5 and τconstriction = 104.8 ± 10.0 sec, n = 5. We 
observed statistically significant difference between the time constants for arteriolar 
relaxation and constriction. After eNOS blockade the relaxation time constant obtained 
was τrelaxation = 31.9 ± 4.97 sec, n = 3 and the constriction time constant was τconstriction = 
51.1 ± 2.5 sec, n = 3. Under similar conditions, we investigated the contribution of NO by 
inhibition of the EDHF component. The time constants obtained were τrelaxation = 29.1 ± 
4.2 sec, n = 3 and τconstriction = 143.5 ± 18.2 sec, n = 3.   
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Fig 2.3. Time constant for vascular response to exogenous Ca2+. (A) Vascular 
response to Ca2+ influx triggered by subjecting the arterioles to exogenous Ca2+ -
containing (A23187, 10 µM) and Ca2+ -free (EGTA, 0.5 mM) solution; n = 5, along 
with EDRF blockade (L-NAME, 0.5mM, n = 3). (B) Relaxation observed after 
EDHF blockade (apamine; 50nM and Tram-34; 100nM, n = 3), followed by 
inhibition of EDHF and EDRF (apamine, 50nM, Tram-34, 100nM and L-NAME, 
0.5mM, n = 3). (C) Time constants for the relaxation and constriction of the 
arteriole (D) after EDRF blockade (E) after EDHF blockade. The time constants 
were calculated by curve fitting the experimental data from Fig. 2 (A - B) with *p < 
0.05 considered statistically significant for a student’s t-test. 
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Acetylcholine has widely been reported to stimulate endogenous NO release [28]. 
Due to wide discrepancy in physiological concentration of NO production, endogenous 
mediator such as Ach provided a better choice as a source of NO. We repeated the 
experiment by subjecting the arterioles to intraluminal perfusion of NO stimulator (Ach, 
10 µM) followed by NO scavenger (oxy-hemoglobin, 100 µM). The arterioles fully 
relaxed to Ach (10 µM) with τrelaxation = 19.2 ± 0.9 sec, n = 9. The constriction to oxy-
hemoglobin (100 µM) was much slower with τconstriction = 92.6 ± 8.1 sec, n = 9. Following 
EDHF inhibition with apamine (50 nM) and tram-34 (100 nM), the arterioles exhibited 
vascular responses with τrelaxation = 30.7 ± 1.7 sec, n = 4 and τconstriction = 83.63 ± 8.1 sec, n 
= 4. After eNOS blockade with L-NAME (0.5 mM), in absence of NO, the time constants 
obtained were τrelaxation = 34.0 ± 14.5 sec, n = 6 and τconstriction = 56.1 ± 9.0 sec, n = 6. The 
arteriolar relaxations were completely abolished after incubation with a cocktail of 
apamine (50 nM), tram-34 (100 nM) and L-NAME (0.5 mM), n = 4.  
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Fig 2.4.Time constant for activation and deactivation of the vessel tone response to 
NO release with Ach. (A): A scenario of NO delivery is created by subjecting the 
arteriole to NO mediator Ach, (10 µM) which stimulates endogenous NO release. 
This is followed by a period of no NO release, where the available NO is scavenged 
by intraluminal delivery of oxy-Hb (100µM). (B): The diameter response was 
observed after blockade of EDHF component with cocktail of apamine (50nM) and 
Tram-34 (100nM), n = 4, followed by a blockade of both EDHF and EDRF 
component with a combination of apamine (50 nM), Tram-34 (100 nM) and L-
NAME (0.5 mM), n = 3. (C): Time constants for the activation and deactivation of 
the arteriole and (D) after EDRF blockade (E) after EDHF blockade calculated by 
curve fitting the experimental data from (A - B) with *p < 0.05 considered 
statistically significant for a paired t-test. 
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2.3.3 Endothelial Ca2+ response induced by exogenous Ca2+ delivery 
     In Fig 2.5, we demonstrated endothelial Ca2+ response from intact pressurized 
mesenteric arterioles loaded with fura 2-AM. The fluorescence signal expressed as 
F340/380 ratio was obtained from the vessel subjected to an induced Ca2+ pulse of duration 
d = 10 sec and period T = 60 sec. The observed Ca2+ response mimicked the induced Ca2+ 
delivery in the vessel with a duration of 10 sec.  
 
Fig 2.5. Ca2+ response from vessel loaded with fura2-AM. Demonstration of induced 
Ca2+ pulse scenario (duration d = 10 sec and period T = 60 sec) achieved with rapid 
switching of Ca2+-containing A23187-4Br, 10 µM and Ca2+-free (EGTA, 0.5 mM) 
solutions. 
2.3.4 Frequency-dependent effect of endothelial Ca2+ induced nitric oxide release on 
vascular responses 
     In Fig 2.6, we demonstrated the frequency-dependent effect of Ca2+mediated NO 
release on vascular responses in rat resistance arterioles. A sequential bursting of Ca2+ 
was achieved by rapid switching between a Ca2+ (A23187, 10 µM) and 0Ca2+ (EGTA, 
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500 µM) solution. We modulated the Ca2+ pulse by varying the duty cycle ratio, d/T. A 
duty cycle ratio d/T = 1; denoted sustained Ca2+ delivery, whereas, d/T < 1 indicated 
transient delivery of Ca2+. For different duty cycle ratio the changes in diameter were 
tracked in real time. For a constant duration d, the duty ratio is a function of frequency 
(1/T). We demonstrated vascular responses for burst duration d= 10 sec and period T=15, 
20, 30, and 60 sec respectively, Fig 2.6A (i -iv). To test the contribution of NO in 
frequency-dependent vascular responses, we repeated the experiments with EDRF 
blockade (Fig 2.6 B). We observed significantly compromised vascular responses 
following EDRF blockade. The vascular response to frequency dependent NO release 
was seen after EDHF blockade (Fig 2.6 C). In Fig 2.8, we presented steady state 
normalized diameter values calculated by fitting the data presented in Fig 2.6 (A - C) to 
monoexponential activation function,	ܦ෡ ሺݐሻ ൌ ܦ௦௦ ∙ ቀ1 െ ݁
ష೟
ഓ ቁ, where Dss is the steady 
state diameter, τ is the time constant. The observed relaxation with duty cycle ratio, d/T = 
10/15, 10/20, 10/30 and 10/60 were 92.6 ± 1.2%, 67.1 ± 1.0%, 60.2 ± 0.9%, and 31.5 ± 
0.8% respectively for n = 3. After EDHF blockade with apamine (50 nM) and tram-34 
(100 nM) the relaxation were 55.2 ± 0.7%, 50.6 ± 2.1%, 27.4 ± 0.4%, and 21.6 ± 0.3% 
respectively for n = 3. These relaxation were significantly compromised after EDRF 
blockade with L-NAME (0.5mM). The observed steady state values were 27.7 ± 0.5%, 
19.3 ± 0.6%, 19.2 ± 1.9%, and 14.1 ± 0.3% respectively for n = 3.  
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Fig 2.6 A: 
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Fig 2.6 B:  
 
 
 
 
 
 
0 30 60 90 120
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Time (sec)
N
or
m
al
iz
ed
 D
ia
m
et
er
 |     d    |
|← ----T----→ |
0 30 60 90 120 150 180 210 240
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Time (sec)
N
or
m
al
iz
ed
 D
ia
m
et
er
|  d  |
|← ----T----→ |
0 30 60 90 120 150
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Time (sec)
N
or
m
al
iz
ed
 D
ia
m
et
er
|    d   |
|← ----T----→ |
0 30 60 90 120 150 180 210 240
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Time (sec)
N
or
m
al
iz
ed
 D
ia
m
et
er
|   d |
|← --------------T------------→ |
ii. i. 
iv. iii. 
28 
 
Fig 2.6 C:  
 
 
 
Fig 2.6. Vascular relaxation to Ca2+ frequency-mediated NO release. (A). 
Frequency-dependent Ca2+ delivery scenario created by varying the Ca2+ pulse 
period T with a constant duration d. A ratio of d/T = 1 denotes a continuous 
delivery, whereas, d/T < 1 indicates a transient delivery of Ca2+. Subsection (i – iv) 
presents the relaxation response of the arteriole for burst period, T = 15, 20, 30, 60 
sec respectively over a constant duration d = 10 sec. (B) after EDRF blockade (C) 
after EDHF blockade. 
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     Similar study was repeated with endogenous source of NO, Ach (10 mM) and oxy-Hb 
(100 mM) as a scavenger of NO. In response to endogenous NO production stimulated 
with Ach, the observed steady state relaxation for duty cycle ratio d/T = 2/3, 1/2, 1/3 and 
1/6 were 87.9 ± 0.8%, 76.4 ± 0.7%, 66.2 ± 1.4%, and 51.4 ± 2.9% respectively for n = 4. 
After EDHF blockade with apamine (50 nM) and tram-34 (100 nM) the relaxation were 
68.4 ± 0.9%, 56.5 ± 0.9%, 42.8 ± 1.0%, and 35.1 ± 2.3% respectively for n = 4. These 
relaxation were significantly compromised after EDRF blockade with L-NAME 
(0.5mM). The observed steady state values were 21.8 ± 0.7%, 12.3 ± 0.4%, 10.8 ± 0.5%, 
and 10.6 ± 0.4% respectively for n = 4. The results are depicted in Fig 2.7. 
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Fig 2.7. A: 
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Fig 2.7. B: 
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Fig 2.7. C: 
 
 
 
Fig 2.7. Vascular relaxation to frequency-dependent NO release. (A). Frequency-
dependent endogenous NO release was induced with Ach 10 µM and NO scavenger 
oxyHb (100 µM). A ratio of d/T = 1 denoted a continuous NO production, whereas, 
d/T < 1 indicated a transient production of NO. Subsection (i – iv) presents the 
relaxation response of the arterioles for burst duration, d= 20, 10, 15, 5 sec 
respectively over a constant period T = 30 sec. (B) after EDRF blockade (C) after 
EDHF blockade. 
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The following figure summarizes the frequency-dependent activity by Ca2+ induced NO 
release 
 
Fig 2.8. Frequency-dependent effect of induced nitric oxide release. The figures 
represent the steady state diameter obtained by fitting the experimental data of (A): 
Ca2+ responses (Fig. 2.6) and (B): Ach (Fig. 2.7) to a monoexponential activation 
function. 
2.4 Discussion 
     Majority of the studies related to NO bioavailability have assumed constant NO 
production, however little emphasis has been directed towards frequency-dependent NO 
release. The eNOS activity could be modulated by Ca2+ binding which may translate 
oscillations in the intracellular Ca2+ into bursts of NO production [37; 147; 148]. This 
generates favorable conditions for transient release of NO. A number of studies have 
reported transient Ca2+-dependent release of NO [149; 150; 151]. It is likely that NO 
might be released in two states: a steady NO that maintained basal vaso-dynamic tone 
and an oscillatory NO component which occurred in bursts to mimic the intracellular 
calcium oscillations. The Ca2+ signaling efficacy and its information processing 
efficiency is greatly enhanced by combined amplitude and frequency modulation [152]. 
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Several biological processes are shown to be regulated by Ca2+ frequency modulation 
such as fluid secretion by salivary glands [153], activation of cysteine protease calpin 
[154] or glycogen metabolism by hepatocytes [155].   
     The kinetics of NO binding to sGC is seen as a rate limiting step for sGC activation or 
deactivation leading to cGMP formation and tone regulation [52]. On similar lines, in our 
previous theoretical study [72], we incorporated the mechanisms of transient sGC 
kinetics to describe cGMP formation. Our mathematical model for NO transport in the 
arterioles predicted optimal conditions for transient NO release. A range of parameter 
values were tested for production rate, consumption rate and concentration of half 
maximum NO activity. Varying these parameters caused either the frequency or 
amplitude dependent control of cGMP formation. Significant enzyme activation was 
predicted under both transient (d/T < 1) and sustained (d/T = 1) NO release scenario. It 
was concluded that if NO release is transient and the cGMP formation is under 
frequency-dependent control, the system is less sensitive to the presence of NO 
scavengers. A transient NO released with a burst duration and period corresponding to 
the activation and deactivation half life of downstream targets such as sGC could trap NO 
[47].Modulating the frequency of such stimulus can potentially accumulate NO responses 
and show improved efficacy towards maintaining vascular tone. This encouraged us to 
design experiments to test if NO carried Ca2+ frequency encoded information and 
translated it into vascular responses.    
     We found that exogenous perfusion of Ca2+ induced rapid relaxation (time constants 
20.8 ± 2.2 sec), followed with a much slower constriction after subsequent removal of the 
stimulus (time constants 104.8 ± 10.0 sec). On the same line, Bellamy et al. [49] 
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previously demonstrated that recovery from sGC desensitization resulted in a half time of 
1.5 min after a rapid sGC activation by NO. Another study in the presence of NO 
scavenger such as oxy-hemoglobin showed that the rate constant for reversal of NO-sGC 
to ferrous sGC was 0.28 min-1 or a half life of 2.9 min at 37ºC [69]. In contrast, few 
studies have documented faster dissociation rates [70]. Such observations with the 
acceleration of NO-sGC dissociation were correlated to the availability of substrates or 
ligand concentrations [71]. Moreover, after the eNOS inhibition with L-NAME the 
fivefold difference in the time constants was significantly reduced (Fig 2), indicating NO 
dependent pathway mediated such responses. In addition, vascular tone has been reported 
to include EDHF and EDRF dependent mechanisms [156; 157]. Our results suggested 
60.3% contribution to vascular relaxation from EDRF and 36.9% from EDHF. Vascular 
relaxation independent of EDHF and EDRF contribution has also been reported [158], 
however we found such contribution to be not significant. After an EDHF blockade with 
apamine and tram-34 combination, we observed a significant difference in the time 
constant for relaxation (29.1 ± 4.2 sec) and constriction (143.5 ± 18.2 sec). To confirm 
our findings we repeated these experiments with an endogenous source of NO (Ach, 
10µM). Ach induced responses closely mimicked the observations obtained from Ca2+ 
perfusion experiments. These observations established that NO-mediated mechanisms 
could store time dependent information to regulate the vascular tone.  
     Ca2+ or its endothelial target NO when modulated at different frequencies could 
regulate vascular tone [134]. For different Ca2+ frequency scenario (d/T = 10/15, 10/20, 
10/30, 10/60) we tracked changes in the vascular response. It was found that the arterioles 
exhibited summation effect with an increase in Ca2+ frequency and attained different 
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steady state tone. Such behavior might be due to an accumulation of NO response 
resulting from sequential Ca2+ bursting. In addition, an interesting observation was that a 
fourfold increase in the Ca2+ frequency improved the efficiency of arteriolar relaxation by 
61.1% (Fig 2.8). This observation corroborated with Dolmetsch et al theoretical study 
which concluded that frequency of Ca2+ oscillations activated the enzymatic target more 
efficiently than constant Ca2+ signaling [136]. The frequency-dependent activity observed 
was significantly compromised following EDRF blockade in comparison to EDHF or a 
combined response.  
     Regulating the availability of NO in the vasculature has been demonstrated to have 
vasoprotective effects. In addition, modulating the bioavailability of NO by different 
means has proved to restore endothelial function. The complex interplay of NO mediated 
activity in multiple systems may suggest a wide range of stimulus to initiate 
physiological responses under different conditions. The efficacy of NO action thus would 
require a detailed attention towards achieving an optimized NO delivery mechanism that 
would mimic the physiological NO activity as closely as possible. In summary, we 
conclude by suggesting NO to encode frequency-dependent information to modulate 
vascular tone. Attention to the frequency aspect of NO release might provide a more 
efficient way to facilitate optimal NO delivery.  
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CHAPTER 3 
Agmatine Induced NO-Dependent Rat Mesenteric Artery Relaxation and its 
Impairment in Salt-Sensitive Hypertension 
3.1 Introduction 
     Over the past two decades there has been a significant interest in understanding vaso-
regulation and the role of nitric oxide in mediating relaxation. Arginine, a precursor to 
nitric oxide has shown to play an important physiological role in regulating the 
endogenous NO levels. L-arginine is required for optimal NO synthesis by nitric oxide 
synthase (NOS) in the rat mesenteric artery wall [76]. The importance of L-arginine as a 
therapeutic element  in various physiological and patho-physiological processes such as 
wound healing [77; 78], protein synthesis and muscle building [79], endocrine 
metabolism [80], erectile dysfunction [81], cardiovascular functions [82; 83; 84] has 
widely been reported.  
     It is suggested that L-arginine acts as a substrate for NOS to facilitate NO production 
[85]. The reported Km values for NOS isozymes range in 2-20 mM [85], particularly for 
eNOS it is reported to be 2.9 µM [86]  and the intracellular L-arginine levels are in the 
range of 0.8 – 2 mM[87]. This would suggest that these enzymes are saturated with the 
substrate however it is observed that the rate of NO production varies with extracellular 
L-arginine concentrations [88; 89; 90]. If exogenous L-arginine acts as substrate and is 
present in saturating concentrations there should be a continuous production of NO. This 
discrepancy is widely referred to as L-arginine paradox [84]. There have been various 
mechanisms hypothesized to explain this behavior [91; 92; 93; 94]. However there still 
exists an ambiguity in understanding how L-arginine mediates NO dependent relaxation.   
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     Supplying arginine to the endothelial cells and vessels contributes to the enhanced NO 
synthesis and vessel relaxation despite its saturating cellular levels. There have been 
various mechanisms hypothesized to explain this arginine paradox including endogenous 
NOS inhibitors and compartmentalization of intracellular L-arginine [91; 92; 93; 94; 
159]. However, there still exists an ambiguity in understanding how exogenous L-
arginine mediates NO-dependent relaxation. The apparent benefits of L-arginine 
supplementation are difficult to reconcile with a purely substrate based mechanism for 
NO synthesis. In addition to the beneficial effects of exogeneous arginine, recent study 
has demonstrated a possible role of agmatine as a potential vasodilator substance [95].  
     Agmatine [4-(aminobutyl) guanidine] is produced endogenously via decarboxylation 
of L-arginine by the endothelial arginine decarboxylase (ADC) [160] and it does not act 
as a substrate for NOS. A biological function for agmatine was suggested based on the 
observation that ADC activity transiently increased 7-fold during cerebral ischemia 
[161]. In addition, the importance of agmatine has been highlighted by its discovery as a 
novel neurotransmitter [96; 97] demonstrating its potential to affect multiple biological 
targets [98]. The presence of agmatine in serum [103] suggests a physiological role in the 
vasculature. Agmatine was demonstrated to serve as a ligand for imidazoline and/or α-2 
AR [162] and α-2 AR agonists mediate endothelium-dependent relaxation in mouse and  
rat aorta [163]. α-2 ARs (G-protein coupled receptors) play a pivotal role in the 
cardiovascular system and influence vascular tone at multiple points. These receptors are 
targets for antihypertensive therapy and their stimulation produces long lasting drop in 
systemic blood pressure [164]. However, the signaling mechanisms participating in 
agmatine-initiated NO synthesis [165; 166] and regulation of vascular tone is little 
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understood, and the contribution of α-2 ARs is implicated in this process [165]. 
Compromised NO synthesis and endothelial dysfunction has been reported in the 
hypertensive vasculature including in salt-sensitive hypertension [167]. However, the 
factors that are responsible for its impaired synthesis are varied and not clearly 
understood. Impaired α-2 AR function has been documented in several models of 
hypertension [168; 169]. However, it is unknown whether this impairment is a cause or 
effect of hypertension.  
     Our hypothesis that explains arginine’s NOS substrate independent actions via the 
activation of α-2 adrenergic receptor (α-2 AR) was demonstrated in cultured endothelial 
cells [165]. In this chapter, we show that arginine-mediated arteriolar relaxation are due 
to agmatine produced by the actions of ADC and signaling via GPCR in rat 
microcirculation. Evidence is also presented documenting attenuated agmatine-mediated 
relaxation in Dahl salt-sensitive hypertensive rat mesenteric resistant arterioles, which 
was attributed to reduced α-2 AR gene expression. The figure below shows the structural 
similarities between L-arginine and its decomposition product agmatine.  
 
Fig 3.1. Structure of L-arginine and Agmatine, both displaying guanidinium group 
similar to imidazolines known to act as ligands for I-receptors and α-2 receptors, 
Figure taken from Joshi et al. [89].  
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3.2 Materials and Methods 
3.2.1 Animal Model 
     Male Sprague Dawley and Dahl salt-sensitive (SS/JrHsd) rats and their diet were 
purchased from Harlan Laboratories (Madison, WI). Sprague Dawley rats were 
maintained on standard pellet chow (2018 Teklad Global) rodent diet whereas the Dahl 
salt-sensitive rats were fed 0.49% NaCl diet (Harlan Cat. #TD 96208) or 4% NaCl diet 
(Harlan Cat. #TD 92034).The animals were housed in temperature and humidity 
controlled rooms with 12 hour on/off light cycle at the animal care facility. All animal 
studies were performed following Institutional Animal Care and Use approved 
procedures.   
     After acclimatization for 1 week, 6-weeks old Dahl salt-sensitive rats were separated 
into 2 diet groups; normal salt (NS), fed 0.49% NaCl diet and high salt (HS), fed 4% 
NaCl diet for 5 weeks. Systolic blood pressure was measured weekly with the tail cuff 
method [170]. At 11 weeks old, HS rats consistently demonstrated sustained hypertension 
(BP > 200 mmHg) while NS rats remained normotensive (BP < 160 mmHg) (Fig. S2). 
The rats were euthanized and vascular reactivity assessed on isolated, cannulated and 
pressurized mesenteric arterioles as described above.  
3.2.2 Isolated mesenteric arteriole preparation 
     Resistance mesenteric arterioles of the second or third order (resting diameter < 150 
µM) were isolated from male Sprague-Dawley and Dahl rats (250-300 g), cleaned of the 
surrounding tissue and cannulated at both ends on glass cannula. The organ chamber was 
maintained constant at 37°C by superfusion with a modified Krebs-Ringer solution 
containing (mM): NaCl 145, KCl 5, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, HEPES 20, and 
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Glucose 10.1 pH 7.4 [171]. Cannulated vessels were axially pre-stretched to remove any 
bents and to simulate physiological stretch conditions. The vessels were pressurized at 50 
mmHg and allowed to equilibrate for 60 min before initiating the experiment. To 
estabilish a concentration that gave submaximal constriction, we constructed a dose 
response curve to norepinephrine. The vessels were preconstricted with continuous 
superfusion of norepinephrine, (NE, 2 µM) and only those that retained a constant 
pressure and a consistent constriction to NE, and fully responded to the agonist were 
included in the study (Fig. 5.2). Ach relaxation was performed on these vessels to test 
intact endothelium. The vessel reactivity study was carried out by intraluminal perfusion 
with various agonist concentrations. This was achieved by an automated solenoid valve 
controlled pressure driven perfusion system. Diameter measurements were tracked in real 
time by mounting the perfusion chamber on the stage of an inverted microscope 
(Olympus) fitted with a CCD camera (QImaging). Post analysis was performed with 
IPLAB (BioVision Technologies) and MATLAB (MathWorks) software. Chemicals NE, 
L-NAME, RX821002, agmatine, L-arginine were obtained from Sigma-Aldrich Co. (St. 
Louis, MO) and Pertussis toxin (PTx) were obtained from Tocris Bioscience (Ellisville, 
MO).  
3.2.3 Real Time-Polymerase Chain Reaction (RT-PCR) 
     RT-PCR was carried out on mesenteric tissue isolated from Dahl rats [172; 173], 
cleaned of fat and stabilized with RNAlater(Qiagen). RNA purification was done by 
homogenizing tissue (~30 mg) with a sonicator in RLT buffer (Qiagen). The lysate was 
repeatedly centrifuged (10,000 g) with reagents from RNeasy® Fibrous Tissue Mini Kit 
(Qiagen) to ensure RNA isolation. A first strand cDNA synthesis was performed by using 
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purified mRNA by Superscript III RT (Invitrogen) in a thermocycler (MJ Research).  The 
new cDNA strand was purified with QIAquick® PCR Purification Kit (Qiagen). Pure 
cDNA (~10 ng) was reacted with Power SYBR Green PCR Master Mix reagent (Applied 
Biosystems) in RNase-free water in a StepOne RT-PCR system (Applied Biosystems). 
The relative expression of α-2A, α-2B AR and eNOS was determined using β-actin as a 
housekeeping gene. The primers used were: α-2A; TTT GCA CGT CGT CCA TAG TG 
(forward) and CAG TGA CAA TGA TGG CCT TG (reverse). α-2B; AAA CAC TGC 
CAG CAT CTC CT (forward) and CTG GCA ACT CCC ACA TTC TT (reverse). eNOS; 
CAA CGCTAC CAC GAG GAC ATT (forward) and CTC CTG CAA AGA AAA GCT 
CTG G (reverse). β-actin; TCC TAG CAC CAT GAA GAT C (forward) and AAA CGC 
AGCTCA GTA ACA G (reverse). Standard curves (initial amount of cDNA versus Ct 
values) were tested for each set of primers demonstrating that for the similar range of 
total cDNA amplification the efficiency of target genes and housekeeping gene (β-actin) 
were equal. No reverse transcription control was used where the PCR reaction was run in 
the absence of reverse transcriptase. Expression of the gene of interest was divided by the 
housekeeping gene and expressed as fold-change compared with the corresponding 
normal-salt rat group.  
3.2.4 Ca2+ fluorescence and HUVEC cell culture 
     HUVECs were obtained from American type culture collection (ATCC, Manassa, 
VA). The cells were cultured in media consisting of modified Kaigan’s F-12 
supplemented with 10% FBS along with 0.1 mg/ml heparin, 0.03 mg/ml endothelial 
growth supplement. Antibiotics (100 units/ml penicillin and 10 µg/ml streptomycin) were 
added in humidified UV irradiated hood. The cells were cultured in T75 flasks and 35mm 
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cell culture plates in humidified incubator at 37C and in a 5% CO2/95% air atmosphere. 
For these study cells were used for eight passages. The Ca2+ florescence experiment were 
carried out with FluoForte calcium dye (4 µM). The cells were loaded for 30 min dye and 
Ca2+ responses were recorded with excitation at λ = 490 nm and emission at λ = 514 nm 
on an florescent microscope with video caliper.    
3.2.5 Data analysis 
     All relaxations were expressed as percentage of norepinephrine (2 µM) induced 
contraction. To analyze vasodilation, we determined the maximal response and EC50 
were calculated by fitting the concentration-response relationship to a logistic function. 
Amplified transcripts from RT-PCR were quantified using the comparative threshold 
cycle method (2-∆∆Ct) with β-actin as normalizer and the corresponding sample from the 
normal salt fed rat mesentery as internal control.  
     All data unless stated otherwise were expressed as mean ± SEM with n representing 
independent rat experiments. Statistical significance was tested using a paired t - test with 
p < 0.05 considered significant.  
3.3. Results 
3.3.1 L-arginine-mediated relaxation is dependent upon ADC activity 
     We carried out relaxation studies using isolated 2nd order rat mesenteric arterioles in 
an intraluminally perfused vessel bath supplemented with increasing concentration of L-
arginine. As shown in Fig. 1A, arginine dose-dependently relaxed the vessel with an EC50 
value of 5.8 ± 0.7 mM (n = 9). The requirement of mM levels of arginine prompted us to 
hypothesize that the actions of arginine may be mediated via its metabolism to agmatine 
by ADC, which is shown to be localized in the endothelium. The relaxations to arginine 
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were significantly inhibited in the presence of ADC inhibitor, DFMA (Fig. 3.2A: EC50, 
18.3 ± 1.3 mM; n = 5). DFMA is a specific inhibitor of ADC [174; 175] and its 
specificity in our system was verified by the absence of any effect on agmatine-mediated 
vessel relaxation (Fig. 3.2B). Thus, this experiment demonstrated that the arginine’s 
actions are mediated by the formation of agmatine. 
3.3.2 Agmatine-induced vessel relaxation 
     To examine the effect of agmatine treatment on vessel tone, the isolated 2nd order 
mesenteric arterioles were subjected to different agmatine concentration by intraluminal 
perfusion. Agmatine relaxed the vessel in a dose-dependent fashion with an EC50 of 
138.7 ± 12.1 µM (Fig.3.2B; n = 22). Thus, significantly less agmatine was required as 
compared to arginine for arteriolar relaxation. As demonstrated in Fig 1B, the agmatine-
mediated relaxation was partially NO dependent as eNOS inhibitor, L-NAME (0.5 mM) 
significantly attenuated the relaxation (EC50, 346.0 ± 19.4 µM; n = 4).  
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Fig 3.2. Concentration-dependant relaxation responses to L-arginine and 
agmatine.(A). Dose-response to intraluminal perfusion of L-arginine (n =9) in 
Sprague-Dawley rat mesenteric arterioles and after pre-treatment with arginine 
decarboxylase blocker, DFMA (0.5 mM), (n =5). *p < 0.05 vs. L-arginine + DFMA. 
(B). Concentration dependent dose response curve to intraluminal perfusion of 
agmatine in rat mesenteric arterioles in the presence and absence of an eNOS 
blocker, L-NAME (0.5 mM), n =4 and arginine decarboxylase blocker, DFMA (0.5 
mM), n =3. Values are mean ± SE with; *p < 0.05 vs. agmatine + L-NAME; **p > 
0.05 vs. agmatine + DFMA. 
3.3.3 α-2 AR activity in agmatine-mediated relaxation 
     It has been previously reported that agmatine binds as a ligand to the α-2 ARs [106; 
108]. To validate if the agmatine-induced relaxation is mediated via α-2 AR binding, we 
treated the vessels with agmatine in the presence and absence of RX821002, a specific 
antagonist of α-2 AR. As shown in Fig 3.3A, RX821002 partly attenuated agmatine-
mediated relaxation (EC50, 1498.0 ± 294.0 µM; n = 6) showing that α-2 AR may be 
participating in the relaxation process. These data corroborate our earlier observation in 
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cultured HUVECs using another selective α-2 AR antagonist, rauwolscine, where it 
attenuated agmatine-induced cellular NO synthesis [165]. 
3.3.4 Inhibition of agmatine-mediated relaxation by pertussis toxin 
     To narrow down the downstream mechanism that may be participating in the 
agmatine-induced relaxation, we examined the possible role of G-proteins. We inhibited 
the G-proteins by pretreating the vessel with PTx (100 nM) for 60 min at 37°C. As shown 
in Fig 3.3B, we observed a significantly reduced relaxation as opposed to that due to 
agmatine alone while the EC50 value increased to 1300 ± 91 µM (n = 4). These data show 
that G-proteins are mediators of agmatine-induced vessel relaxation. Similar inhibition 
with PTx was observed in experiments with cultured HUVECs [165]. 
 
Fig 3.3.Role of α-2 AR and G-protein in agmatine-mediated relaxation.(A). Dose 
response to agmatine in Sprague-Dawley rat vessels was obtained in the presence 
and absence of an α-2 AR antagonist, RX821002 (50 nM) (n =6); *p < 0.05 vs. 
agmatine + RX821002. (B). Agmatine relaxation is mediated by G-protein activity 
seen after incubation with PTx (100 nM). Values are mean ± SE with n =4; *p < 0.05 
vs. agmatine + PTx.   
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3.3.5 Arginine and agmatine induced Ca2+ responses in HUVEC 
We further tested if agmatine and arginine induced Ca2+ responses using HUVEC. Fig 
3.4 (A) shows Ca2+ responses to agmatine, 10 µM, n=15. We inhibited the G-proteins by 
pretreating the vessel with PTx (100 nM)  n=8, for 60 min at 37°C. The role of α-2 
receptor and PLC in agmatine induced Ca2+ activity was tested after incubation with a 
specific inhibitor, RX821002 (50 nM), n = 4 and PLC blocker U73122 (10 µM), n = 6 
respectively. The Ca2+ activity from HUVEC was confirmed with Ca2+ ionophore, 
calcimycin (10 µM),  n = 11, and chelation of Ca2+ signal with BAPTA-AM (10 µM), n = 
5, as seen in Fig 3.4 (B).  
 
Fig 3.4.Role of α-2 AR, G-protein and PLC in agmatine-induced Ca2+ responses in 
HUVEC. (A). Agmatine stimulation of HUVEC along with incubation with α-2 AR 
antagonist, RX821002 (50 nM) , n = 4; G-protein inhibitor pertussis toxin, PTX 
(100nM), n = 8 and PLC inhibitor U73122, 10µM, n = 6 . (B). HUVEC stimulation 
with calcium ionophore calcimycin (10µM) along within response after calcium 
chelation with BAPTA-AM (10µM) and Ca2+ free control. Values are mean ± SE. 
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In Fig 3.5(A), we showed the stimulation of HUVEC with L-arginine (5 mM), n = 8. The 
presense of α-2 receptor activity was tested in HUVECs with α-2 receptor agonist 
UK14304, 10 µM, n = 3.  
 
 
Fig 3.5. Ca2+ responses in HUVEC from (A) L-arginine (5mM), n=8 (B). after 
stimulating with α-2 AR agonist, UK14304 (10 µM) (n =3). Values are mean ± SE. 
3.3.6 Arginine and agmatine-mediated vessel relaxation attenuated in DS rats 
     Small size arterioles (100-500 µm diameter) are implicated to contribute significantly 
to the vascular resistance [176; 177]. Accumulating evidence indicates that endothelium-
dependent relaxation is impaired in salt-sensitive hypertension [178; 179; 180]. However, 
the underlying mechanisms have not been clearly delineated. We investigated if the 
agmatine-induced arterial relaxation is affected in Dahl salt-sensitive rats. 6-week old rats 
were placed on a diet containing either 0.49% NaCl (normal salt) or 4% NaCl (high salt) 
for 5 weeks and isolated mesenteric arterial relaxations were recorded in response to 
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agmatine. The agmatine-induced relaxation was greatly inhibited in high-salt as 
compared to normal salt conditions (Fig 3.7A;% max. relaxation, 90.4 ± 1.7% (NS); 19.8 
± 2.4% (HS)) with normal salt rats exhibiting relaxation to physiological agmatine 
concentration (EC50, 143.9 ± 23.4 µM; n = 5).  
Below we see representative images of HUVEC fluorescence pre and post stimulus.  
 
 
 
 
Fig 3.6. Representative fluorescent images of Ca2+ response with fluoforte calcium 
dye (4µM). (A) before and (B) after calcium ionophore A23187 (10µM) stimulus. (C) 
before and (D) after stimulating the HUVEC to Agmatine (10µM). 
 
A. B. 
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The arginine-induced relaxation was as well inhibited in high-salt as compared to normal 
salt conditions (Fig 3.7B;% max. relaxation, 94.7 ± 1.5% (NS); 18.4 ± 5.5% (HS)with 
normal salt rats exhibiting relaxation to physiological agmatine concentration (EC50, 3.5 
± 0.8 mM, n = 3). Ach mediated relaxation was also impaired in vessels from high salt 
rats (Fig. 5.5) and thus verifying the presence of endothelial dysfunction. However, 
relaxation due to an NO donor, SPER-NO was not affected, showing that the signaling 
pathway downstream of NO synthesis is intact in Dahl hypertensive rats (Fig. 5.3). These 
data illustrate that agmatine-mediated signal transduction pathway leading to vascular 
relaxation is severely impaired in salt-induced hypertension. 
 
 
Fig 3.7.Relaxation response to agmatine and L-arginine in Dahl salt-sensitive 
hypertension. (A) agmatine,  n =5 and (B) L-arginine, n = 3, mediated relaxation 
observed in salt-sensitive Dahl rats maintained on high salt, HS (4% NaCl) and 
normal salt, NS (0.49% NaCl) for 5 weeks. Values are mean ± SE. 
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3.3.7 Down-regulation of mesenteric artery α-2 AR mRNA expression in DS rats 
     Since agmatine is proposed to act via α-2 AR binding (Fig. 3.8), we carried out 
mRNA expression analysis of α-2 AR and eNOS in Dahl rats by real time RT-PCR. The 
mRNA expression of α-2A, α-2B AR and eNOS were attenuated in high-salt Dahl rat 
mesenteric arteries (Fig. 3.7B) indicating that mRNA expression levels of these genes 
was reversed during the development of salt-sensitive hypertension. Among the 3 genes 
analyzed, there was a 10 fold under-expression of α-2A AR.  
 
Fig 3.8.Real Time PCR data for α2A AR, α-2B AR and eNOS mRNA expression. 
Mesenteric artery tissue was harvested and total RNA isolated from NS and HS 
rats. The semi-quantitative RT-PCR was carried out using SYBR Green technology 
in a StepOne RT-PCR system. Values are mean ± SE with n =4. 
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3.3.8 Attenuated NO synthesis in Dahl rats 
     Plasma nitrite levels, as a measure of endogenous NO synthesis, were analyzed by 
ozone based chemiluminescence analyzer. The results indicated that NO synthesis was 
significantly attenuated in high salt rats as compared to normal salt rats (Fig. 3A). These 
data are supported by the similar observations made by Fujii et al [181]. 
 
Fig 3.8.Compromised nitric oxide activity in Dahl salt-sensitive hypertension. 
Plasma nitrite concentrations in HS and NS fed Dahl rats (n = 3). 
3.4 Discussion: 
     Although the beneficial effects of arginine in vascular relaxation are well documented 
and appreciated, the mechanism of its action is not clearly understood. Arginine serves a 
major role by acting as a substrate for NOS and synthesizing NO, which in turn 
participates in signal transduction of vascular relaxation. Since millimolar amounts of 
arginine are required to produce measurable NO levels and vasodilation, it was 
speculated that arginine’s metabolic products could be contributing to its observed effects  
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[165]. We have proposed that some of the observed effects of arginine could be attributed 
to its conversion to agmatine by ADC.  
     The important finding in this investigation is that the inhibition of ADC with DFMA 
significantly attenuated arginine-initiated mesenteric arterial dilation, indicating arginine 
to agmatine conversion for the observed relaxation. The endothelium is known to possess 
ADC activity [160], which was documented to mediate an increased vasodilation and 
glomerular filtration rate following arginine infusion into animals  [182]. In macrophages 
under inflammatory conditions, ADC was shown to modulate agmatine levels, which in 
turn down-regulated iNOS catalyzed NO synthesis [183]. As compared to arginine, 
agmatine brought about the relaxation at a significantly lower concentration (EC50, 138.7 
± 12.1 µM; n = 22). The activation of vessel relaxation with µM agmatine shown here is 
physiologically relevant since the plasma agmatine level has been reported in the µM 
range [184]. Agmatine was shown to activate NO synthesis in endothelial cells but the 
mechanism of activation was not elucidated [166]. The partial attenuation of agmatine-
initiated relaxation by L-NAME indicated that agmatine partly triggered the relaxation 
via NO independent pathway. Binding of agmatine to imidazoline or α-2 AR is well 
documented in the mammalian system. Our hypothesis that agmatine acts by receptor 
binding, possibly via α-2 AR, was examined by using an α-2 AR antagonist, RX821002. 
The observation that RX821002 did not completely attenuate agmatine-triggered 
relaxation implied that agmatine may be affecting relaxation partly via α-AR independent 
pathway. Recently, agmatine’s relaxing effects in rat aorta are documented to be via 
small conductance Ca2+-activated K+ channel and ATP-sensitive inward rectifying K+ 
channels, and idazoxan failed to inhibit these relaxations [185]. It appears that rat aorta is 
54 
 
devoid of I-receptors as Musgrave et al [186] have reported the absence of I-receptor 
antagonist effects, and it is likely that agmatine is using alternative pathways of aortic 
relaxation.  
 
 
Fig 3.9.Schematic representation of the proposed receptor-mediated hypothesis for 
arginine/agmatine stimulation of vascular NO synthesis. 
     Since α-2 AR belongs to GPCR family, we tested the effects of G-protein inhibition. 
Pertussis toxin, a potent G-protein inhibitor, considerably attenuated agmatine-initiated 
relaxation. In the present investigation the inhibitory effects of α-2 AR antagonist 
(RX821002) and G-protein inhibitor (PTx) together provide stronger evidence for the 
participation of GPCR in the vasodilatory actions of agmatine. Using 2 knockout mouse 
models, Shafaroudi et al [163] have demonstrated the mediation of endothelial α-2A AR 
in vasodilation via NO-dependent mechanisms. These receptors may play important 
physiological functions as they’re activated by the endogenous ligand norepinephrine. In 
addition, there is evidence for their participation in various pathophysiological 
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conditions. For example, blood pressure was elevated in transgenic α-2A AR knockout 
mice on a normal salt diet [187], showing that α-2A AR activation with specific agonists 
may serve to alleviate hypertensive conditions.  
     Dahl hypertensive rats are reported to exhibit endothelial dysfunction [188] and 
agmatine-mediated vascular relaxation could be impaired in this model. Our 
measurements of agmatine-initiated vessel relaxation showed that relaxation was 
impaired in high salt as compared to normal salt diet fed Dahl rats. This observation 
supports our postulation that α-2A AR activity and associated signaling pathway is down-
regulated in high salt treated rats leading to impairment of agmatine-mediated relaxation. 
Secondly, mRNA analysis by real time PCR showed suppression of α-2A and α-2B AR 
expression in the mesenteric artery isolated from high salt fed DS rats as compared those 
from normal salt fed DS rats. There was noticeably a robust 10 fold down-regulation of 
α-2A AR, which could be the predominant factor responsible for the observed 
abolishment of vessel relaxation in HS rats. Hirano et al [189] have also observed 
attenuated pre- and post-synaptic α-2A AR reactivity in DS rats fed high salt diet.   
     In summary, we have demonstrated the mediation of ADC in the arginine-initiated 
stimulation of rat mesenteric artery relaxation. Physiological concentrations of agmatine 
activated vessel relaxation via α-2 AR and G-protein and this was dependent on vascular 
NO synthesis. It relaxed the vessels at 100 times less concentration as compared to 
arginine and thus making it a physiologically relevant agonist at α-2 AR binding site. 
Most importantly, our investigations have provided a novel mechanistic explanation for 
the observed beneficial effects of L-arginine-initiated vessel relaxation via agmatine 
formation. Lastly, α-2 AR activity, mRNA expression, and agmatine-mediated 
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relaxations are impaired in vessels isolated from high salt loaded Dahl hypertensive rats. 
These findings may help define fundamental aspects of cardiovascular physiology and 
pathophysiology by demonstrating that many effects of arginine are due to its metabolism 
to agmatine. Agmatine supplementation in the diet is anticipated to alleviate the 
endothelial dysfunction associated with vascular hypertension.  
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CHAPTER 4 
Determination of mechanical parameters of rat mesenteric arterioles in Dahl salt 
sensitive hypertension: A theoretical and experimental study. 
4.1 Introduction 
     Mesenteric arteries have been identified as resistance vessels since they contribute 
significantly to overall vascular resistance [109; 190]. These vessels have been shown to 
adapt its vascular tone and structure to regulate blood pressure and flow [191]. Recent 
studies have suggested increased contribution of small resistance arteries and vascular 
wall mechanics towards the development of hypertension [192]. Altered morphological 
structure with complex remodeling of the vasculature is observed in many studies with 
the progression of hypertension [110; 193; 194]. Various targets have been suggested in 
mediating vascular effects that cause mechanical and structural changes in hypertension 
models of DOCA rats [195] and Dahl rats [196]. Differences in the elastin composition 
were reported to be a contributor of small artery remodeling in SHR model [113]. Studies 
on alterations in collagen, non-fibrous extracellular matrix and adhesion molecules have 
also been proposed in different types of hypertension [197; 198; 199].  
     Salt sensitivity has been associated with increased vascular resistance and volume 
retention [116]. Salt intake resulted in narrowing of resistance arteries and impaired 
distension of rat mesentery in ouabain sensitive hypertensive rats [200]. Salt sensitive 
Dahl rats have been consistently observed to develop hypertension when fed a high salt 
diet [115]. These rats frequently developed vascular injury and hardening [201]. 
Morphometric study from mesenteric arteries of genetically modified Dahl rat strain 
suggested increased smooth muscle mass, and vasoreactivity study showed impaired 
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relaxation capability of arteries caused by endothelial cell damage [194]. In another 
study, no difference in the density or diameter of small arterioles was observed in salt fed 
Dahl rats [202]. A study on carotid arteries showed altered mechanical properties with 
salt sensitivity after development of hypertension. However, these were suggested to be 
independent of NaCl diet or transmural pressure [203]. In DOCA-salt hypertension 
complex relation between arterial mechanics and sodium were pointed [110], and in 
another study vascular morphology was shown to be altered without altering the stiffness 
[195].  
     Arteriolar elasticity is determined by the structural composition of the vascular walls 
and by vascular smooth muscle tone. The mechanical properties of these arterioles are 
important as they characterize the stress-strain relationship in the vasculature. The 
vascular tone and regional blood flow in the microcirculation depend on active and 
passive properties of the vasculature. NO has been shown to modulate the elasticity of the 
arterial wall, and loss of NO affects adversely the vascular morphology and plasticity. 
Vascular NO release is shown to improve elastic properties in human arteries [204]. In 
addition, arteriolar stiffness is shown to be regulated by endothelium derived NO and 
hyperpolarizing factor [205].  Altered receptor-mediated responses have been linked to 
vascular remodeling, leading to smooth muscle cell proliferation [206] and endothelium 
dependent hypertension [207]. EDHF acting through Ca2+ activated potassium channels 
(Kca) and NO have shown to regulate peripheral artery mechanics in vivo in humans 
[208] and rats [209]. Increase in smooth muscle cell length is reported to be one of the 
factors responsible for vascular hypertrophy in young hypertensive rats [210]. In 
addition, NO generating vasodilators and cGMP mediated mechanism have been shown 
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to function as a modulator of vascular smooth muscle cell mitogenesis and proliferation 
[211]. NO has been shown to play a functional role in modulating vascular stiffness and 
endothelial dysfunction in hypertension [212].   
  Our previous work has suggested compromised NO-induced vasoactivity in salt 
sensitive hypertension. Here we designed the study to identify the morphological and 
biomechanical alterations in salt loaded hypertensive Dahl rats in comparison to 
normotensive controls. Experiments were conducted under both active (under influence 
of Ca2+ activity) and passive (in absence of Ca2+ activity) conditions. We also formulated 
mathematical models which incorporated the experimental observations to provide 
parameters describing mechanical properties of vascular wall in rat mesenteric arteries. 
The understanding of blood pressure regulation at the tissue level could be greatly 
enhanced by more detailed information on mechanical properties of rat resistance arteries  
under physiological and salt-induced hypertensive patho-physiological condition. 
4.2 Methods 
4.2.1 Animal Model 
     Male Sprague Dawley and salt-sensitive Dahl rats (SS/JrHsd) and their diet were 
purchased from Harlan Laboratories (Madison, WI). Sprague Dawley rats were 
maintained on standard pellet chow (2018 Teklad Global) rodent diet whereas the Dahl 
salt-sensitive rats were fed 0.49% NaCl diet (Harlan Cat. #TD 96208) or 4% NaCl diet 
(Harlan Cat. #TD 92034).The animals were housed in temperature and humidity 
controlled rooms with 12 hour on/off light cycle at the animal care facility. All animal 
studies were performed following Institutional Animal Care and Use approved 
procedures.   
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4.2.2 Preparation of Resistance Arteries 
     Mesenteric arterioles of the second order isolated from the vascular bed were 
separated in cold physiological modified Krebs-Rringer solution containing (mM): NaCl 
145, KCl 5, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, HEPES 20, and Glucose 10.1 with pH 
7.4. Second order branches of mesenteric arterioles were isolated and cleaned of 
surrounding fat and cannulated under dissection microscope. Buffer solutions were 
replaced to carry out experiments in 0Ca2+ (Ca2+-free) and 2.5mM Ca2+ (Ca2+-containing) 
conditions. The vessel chamber was maintained at 37oC. The arterioles were 
preconditioned to obtain reproducible data. We obtained intraluminal pressure-diameter 
relationship with a servo-controlled pump by increasing the intraluminal pressure in 10 
mmHg steps. The resting diameter was determined at 3 mmHg, and the pressures were 
increased upto 120 mmHg for axial prestretch λ = 1.0, 1.1 and 1.3. Vascular thickness 
and external diameter were calculated using a computer aided video imaging system. All 
data were expressed as mean ± SEM and statistical significance were compared with 
Student’s t-test. A value of p < 0.05 was considered statistically significant.   
4.2.3 Uniaxial tensile loading 
     Mechanical properties of mesenteric arteries of Sprague Dawley (SD), low salt fed 
Dahl rat (DS-L) and high salt fed Dahl rats (DS-H) were evaluated by tensile testing. 
Samples inner and outer radius and length were measured and recorded before subjecting 
the sample into the test. Tensile sample preparation and tests were carried out in 
accordance with standard ASTM, D3039M-08 protocol for biomaterials [213]. Tests 
were carried out using a mechanical testing device (Electroforce 3200 test instrument, 
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Bose Corporation, Eden Prairie, MN)  in an uniaxial tensile mode using a 10 N load cell. 
The tests were carried out at a crosshead speed of 0.005 mm/s. Samples were placed in 
the saline chamber in a controlled environment where the temperature was set at 37 oC. 
Samples from each group were tested for calculating elastic modulus. The incremental 
elastic modulus of the sample was determined by calculating the slope of the stress-strain 
curve.  
4.2.3 Calculation of structural and mechanical parameters 
    Wall thickness (WT) and external diameter (D) of the vessel were obtained from the 
meta-analysis of experimental images using IPLAB (BioVision Technologies) and 
MATLAB (MathWorks) software. Cross sectional area (CSA) and wall to lumen ratio 
were calculated as follows: 
Wall Thickness WT ( ) 2iDD −= 4.1 
Lumen Diameter ( )WTDDi ⋅−= 2   4.2                                             
Cross sectional area ( )[ ]WTWTDCSA ⋅−⋅=π    4.3                                                    
Wall to Lumen Ratio ( ) ii DDD ⋅−= 2 4.4 
The stress strain relationship was observed to be non-linear. The stress-strain data were 
fitted by the exponential function by adjusting material constants σ0 and β:  
εβσσ ⋅⋅= e0                                                                                                                     4.5 
The circumferential and axial Cauchy strains were calculated from experimental data as 
experimental as: 
( ) 00 DDDc −=ε and ( ) 00 LLLz −=ε 4.6 
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whereD0is the diameter observed at 2 mmHg intraluminal pressure in the vessel. L0 is the 
initial axial length. The Cauchy stress was calculated as 
( ) WTDP ic ⋅⋅= 2σ and ,CSAFz =σ                                                                          4.7 
wherePis the intraluminal pressure applied with the aid of servo-controller assembly and 
F is the axial load on the vessel. The compliance of the vasculature, i.e. the slope of the 
pressure-diameter relationship, is important in determining the non-linearity associated 
with the stress-strain relationship. This is characterized by incremental elasticity modulus 
which is the slope of the stress-strain curve. We obtained a tangential or incremental 
elasticity modulus by determining the slope of the stress-strain relationship. At any given 
point incremental Young’s modulus (Yinc) is directly proportional to β. An increase in β 
implies an increase in Yinc, which translates to an increase in stiffness calculated by 
.σβ ⋅=incY                  4.8 
4.2.4 Constitutive 4 parameter finite element model 
    We further extended the study by considering the stress-strain relationship to observe a 
non-linear continuum mechanics with arteriole treated as a hyperelastic materialdescribed 
by [214] 
,
E
WS
∂
∂
=                  4.9 
whereS is the second Piola-Kirchhoff stress tensor. We constructed a 2D axisymmetric 
finite element model in COMSOL to describe the integrative vascular biomechanics with 
active and passive components. 
The total strain energy density function of the NE induced active vessel is given by 
.passiveactivetotal WWW +=              4.10 
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The generalized passive strain energy density function is given by [215] 
( )
.
2
1
,1
2
1
MNKLKLMN
Q
ppassive
EEaQ
eCW
=
−=
4.11 
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whereCp, a1=a2 = a3, a4 = a5 = a6, and a7 = a8 = a9represent the passive, orthotropic, 
compressible material constants. The active strain energy function to incorporate the 
SMC activity is given by: 
( )[ ] ,'',1'
21
b
bb
QwithQErfCW zaactive −+=−=
λλθ                                              4.12 
whereCa, b1, b2and b’ are material constants and Erf(X) is a Gaussian error function.  
4.2.4Parameter Estimation 
Case i. Parameter identification from deterministic scenario 
We tested the performance of the model and optimization procedure by implementing a 
deterministic scenario with known parameter values kΘ .  
We implemented optimization algorithm which minimized the following least squares 
cost functions.  
( )
( ) 

 Θ−


=
∧
j
passivekjMODELjMODELpassivekLS
IS
passivek
pypycwhere
c
2
2
,,
,
,,)( 
min
θθ
θ
                           4.13 
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where ( )kjMODEL py Θ,  is the Green Lagrange strain vector computed from Eqs 4.11-12 
for pressure range jp  
At each pressure, mean strain was calculated as: 
( ) ( ) ( )[ ]


= 
=
E
E
n
i
jn
T
MODELj
T
MODEL
E
jMODEL prypryn
py
1
1 ,,....,,
1
,                                       4.14 
In similar way we have identified parameters describing the active component:  
( ) 

 Θ−


=
∧
j
activekjMODELjMODELactivekLS pypyc
2
2
,, ,,)( θθ ,                                        4.15 
where En  is the number of points along vessel over which the strain was averaged. Quasi 
Newton method was implemented to perform the minimization in MATLAB. To test the 
robustness of the identification method runs with random starting points were carried 
within chosen parameter bounds. The obtained parameter values from the deterministic 
scenario implementation are presented in Table 1. 
Case ii. Parameter identification from experimental data 
To obtain the unknown parameters we used the optimization algorithm described in Case 
i, which minimized the following least squares cost functions. 
( ) 


−


=
∧
j passive
jEXPERIMENTjMODELpassivekLS pypyc
2
2
,)( θθ ,                                     4.16 
We first obtained the passive parameters and used them as constants while estimating the 
active parameters. 
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( ) 


−


=
∧
j active
jEXPERIMENTjMODELactivekLS pypyc
2
2
,)( θθ ,                                               
4.17 
where kθ is the vector of constitutive k parameters for identification, jp is the intraluminal 
pressure applied to the mesenteric arterioles over range index j. 
We obtained set of circumferential strain measurements for different axial stretch from 
isolated mesenteric arterioles of Sprague Dawley and salt sensitive Dahl rats. The lumped 
experimental strain measurements EXPERIMENTy were: 
( ) ( ) ( )[ ]


= 
=
E
E
n
i
jn
T
Ej
T
E
E
jEXPERIMENT prypryn
py
1
1 ,,....,,
1
,                                               4.18 
The obtained parameter values for the active and passive case from the experimental 
measurements are presented in Table 2. 
4.3 Results 
     After 5 weeks of salt feeding the high salt Dahl rats consistently developed 
hypertension. These vessels exhibited reduction in lumen diameter and increased vascular 
wall thickness. In addition to testing the morphological characteristics of resistance 
arterioles in the three groups, we determined the mechanical properties from salt fed Dahl 
rats. In fig 4.1, we see the representative strain obtained from 2D axial symmetric finite 
element model for vascular thickness 25µM (Control condition) and 45µM (High salt 
condition).  
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Fig 4.1. Representative strain measurements obtained from 2D finite element, axis 
symmetric rat mesenteric arteriole model of thickness (A) 25µM (Control) and (B) 
45µM (High salt) experiencing 50 mmHg intravascular pressure. 
     In Fig 4.2, we showed the morphological characteristics under passive (0Ca2+) 
conditions. The variation in vascular diameter and thickness were plotted against 
increased intraluminal pressure. We obtained these relationships for three different axial 
elongations (λ = 1.0, 1.1 and 1.3). We observed increased external diameter and thickness 
in high salt fed Dahl rats (DS-H) as compared to low salt fed Dahl rats (DS-L) and 
Sprague Dawley (SD) rats.   
    In Fig 4.3, we plotted the cross sectional area (CSA) and the wall to lumen ratio 
obtained along with change in intraluminal pressure. We observed the hypertensive DS-H 
rats to have a larger CSA and increased wall to lumen ratio as compared to its 
corresponding normotensive controls.  
 
A. B.
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4.3.1 Characterization of passive mechanical properties 
 
Fig 4.2. Variation of diameter and thickness with the intraluminal pressure at 
various longitudinal stretch ratios: λz = 1.0, λz = 1.1 and λz = 1.3 in mesenteric 
arterioles of Sprague Dawley (SD), low salt fed Dahl rats (DS–L) and high salt fed 
Dahl rats (DS-H). Data is mean ± SEM, n = 3 rats. 
 
Fig 4.3. (A) Intraluminal pressure - Cross sectional area and (B) intraluminal 
pressure - wall to lumen ratio relationship at various longitudinal stretch ratios: λz 
= 1.0, λz = 1.1 and λz = 1.3 in mesenteric arterioles of Sprague Dawley (SD), low salt 
fed Dahl rats (DS–L) and high salt fed Dahl rats (DS-H). Data is mean ± SEM, n = 3 
rats. 
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4.3.2 Characterization of active mechanical properties 
     Identical study was performed for 3 different axial elongation ( λ = 1.0, 1.1 and 1.3 ) 
under active stress conditions in presence of 2.5mM Ca2+ and 2.5mM Ca2+ + 10µM NE. 
Here below we demonstrated the morphological characteristics under active stress 
conditions. In Fig 4.4 and Fig 4.5 we see the diameter and thickness relationship under 
active stress conditions.  
 
Fig 4.4.Variation of diameter and thickness with the intraluminal pressure at 
various longitudinal stretch ratios: λz = 1.0, λz = 1.1 and λz = 1.3 in mesenteric 
arterioles of Sprague Dawley (SD), low salt fed Dahl rats (DS–L) and high salt fed 
Dahl rats (DS-H). Data is mean ± SEM, n = 3 rats. 
In Fig 4.5, we showed the arterioles subjected to active stress induced by 10µM NE in 
presence of 2.5mM Ca2+. The arterioles demonstrated significant active tension under 
10µM NE. We observed decreased diameter and increased thickness under 10µM NE. 
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Fig 4.5. Variation of diameter and thickness with the intraluminal pressure at 
various longitudinal stretch ratios: λz = 1.0, λz = 1.1 and λz = 1.3 in mesenteric 
arterioles of Sprague Dawley (SD), low salt fed Dahl rats (DS–L) and high salt fed 
Dahl rats (DS-H). Data is mean ± SEM, n = 3 rat. 
   
Fig 4.6. Intraluminal pressure - Cross sectional area and intraluminal pressure - 
wall to lumen ratio relationship at various longitudinal stretch ratios: λz = 1.0, λz = 
1.1 and λz = 1.3 in mesenteric arterioles of Sprague Dawley (SD), low salt fed Dahl 
rats (DS–L) and high salt fed Dahl rats (DS-H). Data is mean ± SEM, n = 3 rats. 
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   In Fig 4.6 and Fig 4.7 we showed the cross sectional area and lumen to diameter 
relationship under active stress conditions in presence of 2.5 mM Ca2+ and under active 
tension from 10µM NE. 
 
Fig 4.7. (A) Intraluminal pressure - Cross sectional area and (B) intraluminal 
pressure - wall to lumen ratio relationship at various longitudinal stretch ratios: λz 
= 1.0, λz = 1.1 and λz = 1.3 in mesenteric arterioles of Sprague Dawley (SD), low salt 
fed Dahl rats (DS–L) and high salt fed Dahl rats (DS-H). Data is mean ± SEM, n = 3 
rats. 
 Under active tension we observed increased wall to lumen ratio and decreased cross 
section area. Further, we demonstrated the stress strain relationship that characterizes the 
material properties. 
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Figure 4.8. Intraluminal Pressure and Circumferential Strain curves for various 
longitudinal stretch ratios: λz = 1.0, λz = 1.1 and λz = 1.3 in mesenteric arterioles of 
Sprague Dawley (SD), low salt fed Dahl rats (DS–L) and high salt fed Dahl rats (DS-
H). Data is mean ± SEM, n = 3 rats. 
In Fig 4.8, we showed the circumferential pressure and strain relation for passive and 
active 0Ca2+ and 2.5 mM Ca2+ conditions. 
 
Fig 4.9. Axial stress – Axial strain curve in uniaxially loaded mesenteric arteries 
from Sprague Dawley, LS fed Dahl rats and HS fed Dahl rats, n = 5 vessels. Data is 
mean ± SEM. 
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     In fig 4.9, we plotted the axial stress-strain relationship for the three different groups 
of rats. The difference in stiffness was characterized by β as described earlier. The 
obtained results were tabulated in the following table 4.1:  
 Wall Thickness 
(WT, µm) 
Axial Circumferential 
β β 
SD 18.52 ± 1.26  2.344 ± 0.22 2.256 ± 0.60 
DS-L 21.30 ± 1.98  2.188 ± 0.38 1.921 ± 0.38 
DS-H 35.31 ± 2.44 3.713 ± 0.80 1.895 ± 0.42 
Table 4.1.Wall thickness and βvalues for SD, DS-L and DS-H rats. 
4.3.3 Parameter Estimation: 
The parameters obtained from the estimation are tabulated below: 
Case i. Deterministic Scenario 
Table 4.2 A. Passive condition:  
True Value:Cp = 80.568kPa, a1 = 0.521, a4 = 0.251, a9 = 0.391.  
Trial   a1  a4  a9             Cp*100kPa    
1  [0.46935       0.24112      0.40002      0.84892] 
2    [0.53995       0.13283      0.43322      0.92103] 
3   [0.53822       0.24651      0.50981      0.92190] 
4    [0.63975       0.13069    0.33109      0.72203] 
5   [0.71210       0.21991 0.38001       0.78143]   
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Table 4.2 B. Active Condition:  
True Value: Ca = 4.41 kPa, b1 = 0.117, b2 = 0.207, b’ = 20.5.{Parameters obtained from 
Kassab et al. [215]} 
Trial Ca *10kPa  b1  b2  b’*100     
1          [0.62001         0.1997          0.30103            0.18192] 
2                   [0.43301         0.23018         0.20502           0.20495] 
3                   [0.42087         0.18283         0.21196           0.19236] 
4           [0.50123          0.21009        0.47530           0.31576] 
5                   [0.38112          0.10283        0.28201           0.21765] 
Case ii. Parameter identification from experimental data 
Minimizationperformed on mean data from N=3 rats in each group 
Table 4.3 A. Passive Condition: 
Rat   a1  a4  a9         Cp*100kPa      
SD   [0.33190 0.38173    0.12911        0.54210] 
DS-L    [0.48721 0.47903    0.24236 0.40331] 
DS-H    [0.73115 0.68311    0.11173 0.79300]  
 
Table 4.3 B. Active Condition: 
Rat  Ca*10kPa   b1      b2  b’ *100   
SD  [0.67210 0.17060    0.11380       0.30595] 
DS-L  [0.51480 0.31559    0.41750       0.18890] 
DS-H  [0.30991 0.61981    0.54201 0.04211] 
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4.3.4 Statistical Analysis: 
To quantify the ‘goodness of fit’, comparison were made between the 
experimental values and the theoretical predictions with best fit material constants, i.e. 
RMSE were calculated for the fitting.  
4.4 Discussion 
     The pressure-lumen relationship of the resistance arterioles play a critical role in 
maintaining normal blood flow conditions in the vasculature [190]. Altered mechanics 
may lead to arteriolar resistance increases due to vasoconstriction and structural changes. 
Increased resistance of the mesenteric vessels is associated with hypertension, which may 
result from a decrease in the lumen size induced by the contraction of the smooth muscle. 
Pathogenetic malfunction such as impaired endothelium may further augment complex 
remodeling of the vasculature [194]. Under hypertensive conditions, studies have 
suggested that changes in pressure-diameter relationship are influenced with increased 
distensibility in small arteries [217]. Changes in the vascular reactivity could be preceded 
by elevation of vascular resistance and arterial pressure in salt sensitive hypertension 
[192]. In addition, in vivo vessels experience axial strain, and thus characterizing 
circumferential and axial stress-strain aspect associated in mesenteric vessels is 
fundamental to provide better understanding of the patho-physiology of hypertension. 
     Microvascular tone and blood flow are determined by passive biomechanical 
properties of the vessel wall and by active constrictions of the vascular smooth muscle 
cells (SMC). In the vascular smooth muscle cells, increased expression of Ca2+ activated 
K+ channels (IKCa) is associated with smooth muscle cell proliferation [218; 219]. The 
intracellular calcium concentration in SMC is the major determinant of the active tone 
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and is controlled by a complex system of intracellular and intercellular signaling 
pathways [156]. The contractile state of SMCs depends on the intracellular Ca2+ 
concentration and is regulated by an elaborate network of signaling pathways. The SMC-
EC network plays an integral role in modulating signal transmission. Several 
Ca2+dependent channel operations are altered due to changes in vascular morphology. 
Ca2+-dependent volume regulated chloride channel activity is shown to be compromised 
in rat cerebrovascular smooth muscle cell during hypertension [220]. β-adrenergic 
regulation of Na-K-Cl ion transport abnormality was correlated to cytoskeletal and 
smooth muscle altered cell morphology [221]. The glycoprotein tenasin associated with 
remodeling events is expressed in smooth muscle cells of spontaneously hypertensive rats 
[222]. Changes in expression and function of Ca2+-dependent K+ channels is reported to 
be associated to wall structure in hypertension [110; 111]. The intracellular Ca2+ thus not 
only regulates the intracellular contractile response of smooth muscle cell [223] but it 
also causes long term morphological changes by altering gene expression [224] that 
might alter the vascular tone in normotensive [109] and hypertensive conditions [209]. 
Arteries of hypertensive animals have shown increased smooth muscle cell mass as 
compared to normotensive controls which might trigger enhanced vasoconstriction [193]. 
Changes in the contractile properties are reported in resistance arteries of SHR and 
normotensive rats [225]. In animal models, significant changes in the viscoelastic 
properties of the arteries were observed in Goldblatt hypertension [226] and in SHR 
[227] rats. Wall stress generated by intraluminal pressure was significantly smaller with 
reduced elasticity modulus in another study with SHR hypertension model [228]. The 
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differences in the elastic properties are suggested to be a consequence rather than 
precursor to hypertension [113].  
    In this study, we identified whether the passive and active biomechanical properties of 
mesenteric resistance arterioles are altered in Dahl salt sensitive hypertension active. We 
presented material properties of rat mesenteric arterioles in high salt fed hypertensive 
(DS-H) rats in comparison to normotensive low salt fed Dahl rats (DS-L) and Sprague 
Dawley as controls. The salt sensitive hypertension is associated with alteration in the 
morphology of the carotid arterial wall [203]. We examined whether morphological 
alteration occurred in rat mesenteric arteries after salt loading in HS Dahl rats as 
compared to LS and Sprague Dawley as controls.  
     Our evaluation of the mechanical properties of the mesenteric arteries in HS fed Dahl 
rats along with LS fed Dahl rat and Sprague Dawley as control suggested morphological 
changes in HS fed hypertensive rats which included increase in media width and CSA, 
both indicators of vascular growth. Our study with salt sensitive Dahl hypertension model 
demonstrated increased vascular growth with thicker vessel walls. We observed that salt 
loading resulted in vascular remodeling. Our experiments suggested that treatment with 
high salt decreased the lumen to external diameter ratio. The strain was computed from 
the changes in the displacement measurements relative to the zero stress state. From the 
obtained stress-strain relationship we estimated the material properties such as the 
elasticity coefficients associated with the rat mesenteric vessels under normotensive and 
hypertensive conditions. Increased elastic modulus was observed in HS Dahl rats 
suggesting significant changes in the stiffness of the arterial wall components. 
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     The mathematical model could be used to simulate agonist-induced vasorelaxation 
and vasoconstriction, conducted vasoreactivity, myogenic tone and pressure-induced 
diameter changes. This model can also be used to test hypotheses about tone regulation, 
such as the role of myoendothelial projections and extracellular potassium in endothelium 
derived hyperpolarizing factor. Disease-specific changes at the subcellular level can be 
incorporated into the model to predict their effect on responses at the vessel level. These 
observations could facilitate an insight in the pathophysiology of salt sensitive 
hypertension thereby giving us a valuable insight in the abnormalities occurring in the 
mechanical structure of the vessel under hypertensive conditions. This occurs through a 
wide variety of mechanical and biochemical mechanisms that maintain cardiovascular 
equilibrium. An understanding of the physiological factors that regulate the resistance in 
arteriolar circulation is thus important to identify the pathological basis of cardiovascular 
risk such as hypertension. 
     In conclusion, we developed a forward mathematical model to simulate the 
abnormality such as salt sensitive hypertension in rat mesenteric arteriole. Further, we 
proposed an inverse computational model for estimating the elasticity profile of the 
mesenteric arteriole in normotensive and salt sensitive conditions. Our identification of 
coefficients which represented salt sensitivity in mesenteric arterioles can provide an 
insight to streamline causes of salt sensitive hypertension.Thus, the integration of 
subcellular data into a computational model can allow the analysis of complex 
microcirculatory function in health and disease, hypothesis testing, and guide new 
experimentation.  
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CHAPTER 5 
Vascular reactivity study on isolated Dahl rat mesenteric arterioles: A role of 
EDHF, EDRF and α2-adnergic receptor in salt sensitive hypertension 
5.1 Introduction 
     Salt sensitivity possesses a significant health risk as it appears in more than half of the 
hypertension cases. It acts a marker for increased cardiovascular risk in patients with 
essential hypertension. It leads to susceptibility of endothelial dysfunction and vascular 
damage. Many elementary questions regarding the pathophysiology of salt sensitive 
hypertension are vaguely addressed. The mechanisms by which salt intake increases 
peripheral vascular resistance leading to arterial constriction and increase in blood 
pressure have not been clearly understood. 
     It is widely accepted that NO plays an important role in salt sensitive hypertension. 
The L-arginine/NO pathway particularly NO as an EDRF has been the area of keen 
interest. L-arginine supplementation has shown beneficial effects with increased NO 
production in Dahl salt sensitive rats [229; 230]. On the other hand, chronic inhibition of 
NO induced salt sensitive hypertension in control rats [231]. Suppression of  L-arginine-
NO system [232] has emerged as one of the major component in the pathophysiology of 
salt sensitivity. Compromised endothelium-dependent vasodilation has been reported in 
salt sensitive humans [233] and animal models [234; 235].    
     The mechanisms that link salt sensitivity to altered NO activity have not been 
resolved. Recent studies have suggested decreased expression of eNOS, increased NO 
scavenging and decoupling of eNOS in salt sensitivity. Limited NO availability has 
shown to precede development of hypertension [236]. It is not clear if compromised NO 
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bioactivity plays a major role in the pathogenesis of hypertension or if it is a result of 
elevated blood pressure. On the other hand there are experimental findings that have 
suggested NO is not an essential factor for the development of hypertension [237; 238]. 
Both upregulation and downregulation of NO activity has been reported in hypertension 
and there are contradictory reports regarding the role of NO in both humans [239] and in 
hypertensive animal models [240; 241]. In SHR model studies have reported decreased 
endothelium derived relaxation in different vessels including the aorta [242], coronary 
arteries [243], and mesenteric arterioles [244]. These results imply decreased NO 
mediated activity in SHR. On the other hand studies have as well reported no change 
[240] or enhancement [245] of the endothelium dependent relaxation, increased 
expression of eNOS [246] and enhanced overall NO activity of SHR in vivo [247].  
     Distinct endothelial impairment is seen in coronary microvessels from hypertensive 
Dahl rats [17]. Endothelium dependent relaxations are primarily mediated by the release 
of NO (EDRF), prostacyclin or endothelium derived hyperpolarizing factor (EDHF) 
[248]. The relative contribution of EDHF and NO in endothelium dependent relaxation 
has been a subject of wide interest [249]. Observation that EDHF is distinct from NO has 
suggested benefits towards vascular control mechanisms. If one system fails then a 
parallel or back up system could compensate in the vasomotor responses. NO pathway 
and EDHF mechanisms have demonstrated to work in a feed forward associative and 
feedback compensatory mechanisms. Such parallel or backup controls could be produced 
by different signal transduction pathways and may have different downstream effectors. 
Studies have documented inhibitory actions of NO in the production and/or action of 
EDHF suggesting it to follow a negative feedback mechanism [250; 251]. Another study 
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on rat cerebral vessel demonstrated that EDHF responses were not suppressed by NO 
thereby suggesting a functional role for EDHF [252]. NO has as well shown to contribute 
to EDHF responses in small rat arteries [253]. 
     In addition, Chang et.al [254] pointed out that vast majority of the experimental 
studies utilize vascular rings of large vessels and not vessels from microcirculation, 
where the blood flow and pressure are mostly controlled. Large arteries may behave 
significantly differently from the smaller resistance arterioles. In this chapter, we hence 
try to develop a better fundamental understanding of the signal transduction events that 
are involved in the vascular tone regulation in small resistance arterioles of salt sensitive 
hypertensive Dahl rats.  
5.2 Methods 
5.2.1 Animal Model 
     Dahl salt-sensitive (SS) rats and their diet were purchased from Harlan Laboratories 
(Madison, WI). Dahl salt-sensitive rats were fed 0.49% NaCl diet (Harlan Cat. #TD 
96208) or 4% NaCl diet (Harlan Cat. #TD 92034).The animals were housed in 
temperature and humidity controlled rooms with 12 hour on/off light cycle at the animal 
care facility. All animal studies were performed following Institutional Animal Care and 
Use approved procedures.    
     After acclimatization for 1 week, 6-week old Dahl salt-sensitive rats were separated 
into 2 diet groups; normal salt (NS), fed 0.49% NaCl diet and high salt (HS), fed 4% 
NaCl diet for another 5 weeks. Systolic blood pressure was measured weekly with the tail 
cuff method [170]. At 11 weeks old, HS rats consistently demonstrated sustained 
hypertension (BP > 200 mmHg) while NS rats remained normotensive (BP < 160 
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mmHg). The rats were euthanized and vascular reactivity assessed on isolated, 
cannulated and pressurized mesenteric arterioles as described below. 
5.2.2 Isolated mesenteric arteriole preparation 
     Mesenteric arterioles of the 2nd order with external diameter of 380 ± 30 µm were 
isolated from male Dahl rats (250-300 g), cleaned of the surrounding tissue and 
cannulated at both ends on glass cannula (O.D. 200 ± 25 µm). The organ -chamber was 
maintained constant at 37°C by superfusion with a modified Krebs-Ringer solution 
containing (mM): NaCl 145, KCl 5, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, HEPES 20, and 
Glucose 10.1 pH 7.4 [171]. Cannulated vessels were axially pre-stretched to remove any 
bents and to simulate physiological stretch conditions. The vessels were pressurized at 50 
mmHg and allowed to equilibrate for 60 min before initiating the experiment. The vessels 
were preconstricted with continuous superfusion of norepinephrine, (NE, 2 µM) and only 
those that retained a constant pressure and a consistent constriction to NE, and fully 
responded to the agonist were included in the study. The vessel reactivity study was 
carried out by serial addition of various agonist concentrations to the vessel chamber. 
Diameter measurements were tracked in real time by mounting the vessel chamber on the 
stage of an inverted microscope (Olympus) fitted with a CCD camera (QImaging). Post 
analysis was performed with IPLAB (BioVision Technologies) and MATLAB 
(MathWorks) software. Chemicals: All Chemicals  were obtained from Sigma-Aldrich 
Co. (St. Louis, MO)  
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5.3 Results 
5.3.1 Systolic blood pressure of Dahl rats during the 5-week salt treatment 
     High salt diet (HS: 4% NaCl) fed for 5 weeks resulted in significant increase in 
systolic blood pressure (212 ± 4 versus 154 ± 3 mm Hg; P < 0.05) in HS Dahl rats as 
compared to Low Salt (LS: 0.49% NaCl) fed Dahl rats.  
 
Fig 5.1. Time course of systolic blood pressure measured by tail cuff method in Dahl 
rats placed on LS (•) and HS (■) diet for 5 weeks, n=11. The data are expressed as 
mean ± SEM. #P<0.05 vs. LS considered significant. 
5.3.2 Norepinephrine induced vascular constriction 
To establish a concentration that gave submaximal constriction, in Fig5.2, we 
constructed a dose response curve to norepinephrine. The EC50 value observed of 
norepinephrine for LS dahl rats was 0.641 ± 0.17 µM, n = 3and that of HS dahl rats was 
0.457 ± 0.29 µM, n = 3.Exogenously applied norepinephrineinduced consistent 80% 
constrictions at 2µM concentration. This was considered as preconstriction diameter for 
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the relaxation experiments. In our experiment, no significant difference was observed in 
the vascular responses to norepinephrine in both group of rats.  
 
Fig 5.2. Contractile response of mesenteric arterioles to norepinephrine in LS (•) 
and HS (■) fed Dahl rats, n=3. The data are expressed as mean ± SEM. 
5.3.3 Vascular response to Sper-NO and calcimycin 
     We investigated vascular responses to exogenous NO (Sper-NO) and exogenous Ca2+ 
influx with calcimycin in the two rat groups. We observed maximal relaxation elicited in 
both groups in response to Sper-NO and calcimycin. The relaxation observed to Sper-NO 
in LS fed rats was (100 ± 3%,  n= 3) as opposed to high salt fed rats (98 ± 3%,  n = 3). 
Calcimycin induced relaxation was (86 ± 6%, n = 3) in low salt and (87 ± 8%, n = 3) in 
HS fed dahl rats.  
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Fig 5.3. Relaxations to SperNO and calcimycin in 2µM, NE preconstricted 
mesenteric arterioles of LS and HS fed Dahl rats, n=3. The data are expressed as 
mean ± SEM. 
5.3.4 Vascular response to α-2 receptor agonist (UK14304) 
The application of α-2 receptor agonist (UK14304) evoked dose dependent 
relaxation in both groups with a maximum relaxation of  (41 ± 3%, n = 3) in LS fed dahl 
rats. These relaxation were significantly compromised in HS fed rats with a maximum 
obtained response of (19 ± 8%, n = 3).  
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Fig 5.4. Concentration dependent relaxation response to α-2 receptor agonist 
(UK14304) in 2µM, NE preconstricted mesenteric arterioles of LS and HS fed Dahl 
rats, n=3. The data are expressed as mean ± SEM. 
5.3.5 Vascular responses to Ach in salt sensitive hypertension 
The endothelium dependent relaxations evoked by Ach were significantly 
suppressed in mesenteric arteries of HS fed Dahl rats as compared to those of LS Dahl 
rats. The maximal relaxation to Ach was (71 ± 4%, n = 3) in HS group as compared to 
(95 ± 9%, n = 3) in LS group. We investigated the relative contribution of NO and EDHF 
in acetylcholine mediated smooth muscle relaxation. The NOS inhibitor L-NAME 
(0.5mM) reduced the acetylcholine evoked endothelium dependent in both the groups. 
After L-NAME treatment, we observed that acetylcholine induced relaxation were (62 ± 
4%, n = 3) in LS fed rats which were compromised significantly (48 ± 9%, n = 3) in HS 
fed rats as compared to LS group. These relaxations were completely blocked after a 
combined NOS and EDHF blockade with a cocktail of L-NAME (0.5mM), apamin 
(50nM) and TRAM-34 (100nM).  
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Fig 5.5. Concentration dependent relaxation response to acetylcholine in 
preconstricted mesenteric arterioles of LS and HS fed Dahl rats, n=3 with EDRF 
blockade (■) and combined EDRF, EDHF blockade (♦). The data are expressed as 
mean ± SEM. 
5.4 Discussion 
     Salt sensitive hypertension is associated with impaired endothelial function [23]. The 
mechanisms that contribute to such susceptibility remain largely unresolved. A 
relationship between salt sensitivity and hypertension has not been precisely identified. 
The signaling pathways by which salt intake elevates blood pressure have also not been 
clearly elucidated. Hence, to develop a better fundamental understanding we investigated 
the contribution of EDRF, EDHF and α-2 receptor mediated activity in salt induced 
hypertension.  
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5.4.1 Effect of α-2 adreno receptors on vascular responses in SS hypertension: 
     The α-2 adreno receptors are shown to initiate nitric oxide mediated vascular 
relaxation in rats [255]. Such relaxations were initiated by binding of different agonist to 
cell membrane receptors. These responses were observed to be independent of EDHF 
mechanism, primarily mediated via G proteins and EDRF action [256]. Altered α-2 
adreno receptor expression is reported with salt loading in salt sensitive hypertension. 
Studies have demonstrated both upregulation and downregulation of α-2 adreno receptor 
expression [257; 258; 259; 260]. In SHR model dose dependent relaxation was observed 
to α-2 adreno receptor agonist, UK14304, in normotensive wistarkyoto rats (WKY) 
which was significantly compromised in SHR rats.  
     We tested the role of α-2 adreno receptors with a selective and potent agonist, 
UK14304 in salt sensitive dahl rats. We observed that UK14304 only partially relaxed the 
arterioles in LS fed dahl rats. These relaxation were significantly compromised in HS 
Dahl rats. This suggested that α-2 receptor mediated pathways are significantly 
compromised downstream of α-2 adreno receptor in salt induced hypertension.  
5.4.2 Effect of exogenous NO on vascular responses in SS hypertension 
     Exogenous NO delivery has shown to alleviate hypertension in multiple rat models 
[261]. Though wide uncertainty surrounds the precise mechanism of action, the potency 
of its action is widely accepted. Various precursors of NO such as L-arginine when 
supplemented or fed as treatment have produced antihypertensive effects [230; 262]. 
Previously studies have reported significant improvement in relaxation responses to NO 
donating agents in hypertension [73; 263]. We tested the potency of NO donor (Sper-NO) 
in causing an effect in salt loaded Dahl rats. We observed that Sper-NO fully reversed the 
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hypertensive effects. Though ambiguity surrounds the mechanism or its action, it is 
possible that under compromised NO machinery, Sper-NO or NO might initiate 
responses by triggering EDHF -like mechanisms [253; 264; 265; 266]. Sper-NO has 
shown to reduce chloride absorption and improve salt sensitivity in thick ascending limb 
from HS rats [267]. We observed in our experiment that Sper-NO fully recovered the 
relaxation in HS fed Dahl rats. In another salt induced hypertension study, similar 
observations were reported with NO donor sodium nitroprusside[117]. Our observation 
can provide significant insights in designing medications to reverse hypertension.    
5.4.3 Effect of extracellular Ca2+ influx with calcimycin on vascular responses in SS 
hypertension 
Calcimycin, a calcium-mobilizing agent has been reported to cause endothelium 
dependent dilation in the rat mesenteric arteries [268]. EDRF was shown to be a 
candidate in mediating these relaxation responses [269]. The concentration dependent 
relaxation curve of calcimycin is shown to shift to the right following inhibition with 
NOS blocker, NG-nitro-L-arginine [270]. NO has as well been measured directly in-situ 
in rat mesentery after maximal stimulation with the calcium ionophore (10µM) [271]. In 
addition, these relaxations were suggested to be via NO independent mechanism with 
increases in extracellular potassium concentration reflecting EDHF action [272; 273].   
     Extracellular Ca2+ influx is a major determining factor in endothelium dependent 
vascular relaxation. It stimulates the release of both EDRF and EDHF mediated 
relaxation machinery. Contradictory reports have been presented with actions of 
calcimycin in hypertension. In SHR model calcimycin responses are observed to be 
partially compromised and suggested to be a result of decreased NO availability due 
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scavenging of NO rather than reduced NO bioavailability [271]. Decreased constitutive 
endothelial NOS activity is also reported in an extracellular Ca2+  dependent manner 
[274]. The effect of calcimycin was different in various models of hypertension. The 
relaxation to calcimycin was impaired in angiotensin II induced hypertension but was 
unaltered in NE induced hypertension [275]. In DOCA-salt hypertension the endothelium 
dependent dilations to calcimycin were very minimally altered and were reported to be 
not significant [276]. Other study in the same rat model has shown partial inhibition of 
vascular response which was improved after treatment with medication [277].  
     We tested the effect of Ca2+ induced dilations in salt fed Dahl mesenteric arterioles. 
The full relaxation observed to calcimycin in both the groups may be a result of Ca2+ 
mediated compensatory mechanisms between EDHF and EDRF.  
5.4.4 Contribution of EDRF and EDHF in salt sensitive hypertension 
     Ach has widely been reported to induce relaxation by endogenous NO release and 
EDHF activity [121]. Ca2+ activated K+ channels (KCa) in particular the small and 
intermediate KCa (SKCa and IKCa) channels are identified as key players in EDHF 
mediated relaxations of rat resistance arteries [278]. Reduced expression of IKCa and 
SKCa are reported in resistance arteries of angiotensin II induced [279] and high salt fed 
hypertensive rats [280] . Compromised EDHF mediated  relaxation to Ach in rat 
mesenteric arteries from angiotensin II treated rats [281], SHR [282] in comparison to 
control rats are reported. In HS fed Dahl rats partial impairment of relaxation to Ach was 
observed in mesenteric arteries [283], renal arteries [178] and aortic rings [284; 285]. 
Studies have as well reported no difference in relaxation to Ach in mesenteric arteries 
between low salt and high salt fed Sprague Dwaley [286] and Dahl rats [264]. Goto et.al 
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[264] showed that after EDRF inhibition, the relative contribution of EDHF to relaxation 
was significantly greater in HS dahl rats than in LS dahl rats. They suggested these 
EDHF like relaxations were contributed by large conductance calcium dependent 
potassium (BKCa) channels in HS dahl rats but not in LS dahl rats. In their experiments, 
Ach induced (endothelium dependent) relaxations and sodium nitroprusside or 
levcromakalim induced (endothelium independent) relaxations showed no difference in 
the two groups. They concluded that the upregulationof  EDHF by increased BKCa 
activity appeared to compensate for the loss of NO in mesenteric arteries of LS Dahl rats. 
The ambiguity in the available literature has made it difficult to devise a precise 
conclusion and has encouraged us to design our experiments.   
     In our study, we observed that Ach fully relaxed the mesenteric arterioles in the LS 
rats. These relaxations were significantly compromised by 24% in HS rats. In addition, in 
the LS group, after L-NAME blockade the relaxations were compromised to 61%, 
suggesting a contribution of 39% of the relaxation to NO component and rest to EDHF 
mediated relaxation. On the other hand, in the HS group, after L-NAME blockade the 
relaxation were compromised to 48%. This implies 52% of the relaxation was dependent 
on NO component in hypertension. 
In addition, we observed extracellular Ca2+ influx, and exogenous NO to reverse 
hypertension completely. Our previous RT-PCR data has clearly showed compromised 
eNOS expression in hypertensive Dahl rats. We observed α-2 receptor mediated agmatine 
relaxation were ~50% dependent on NO pathway. These relaxation were inhibited in 
hypertensive dahl rats, which resonates with the observed data from UK14304, a potent 
α-2 receptor agonist. 
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     Our observations thus lead us to a conclusion that might suggest improved activity of 
NO -like parallel mechanisms that might try to mimic NO under hypertension. Another 
possibility is NO itself demonstrating hypersensitivity in hypertension. The presence of 
compensatory pathways and the effects of agonists and NO independent relaxation 
mechanisms may possibly mask the effect of NO contribution completely in 
hypertension. The coexistence of NO along with EDHF-like substances and endothelium 
independent relaxation mechanisms would confer compensatory flexibility under 
pathophysiological abnormality such as salt sensitive hypertension. These findings have 
intriguing implications with regards to the bioactivity of NO which is linked to salt 
sensitivity as a marker of increased cardiovascular risk.  
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Summary 
     In our study, we performed in-vitro experiments on isolated rat mesenteric arterioles 
to facilitate better understanding of NO activity in physiological and pathophysiological 
condition such as salt sensitive hypertension. 
     We showed that the frequency-dependent release of NO from the endothelium carried 
encoded information which could be translated into vascular tone. This frequency-
dependent activity of NO resulted from the intracellular Ca2+ frequency dependence of 
the endothelium. This observation might have significant implications towards delivery 
of NO as a therapeutic target to alleviate hypertension. Incorporating the frequency 
aspect of NO release might improve the efficacy of NO activity in NO aided drugs. 
Further studies should explore the contribution of frequency of NO release in a diseased 
model. This study which was carried out with endogenous NO release can be extended to 
a direct administration of frequency-dependent delivery of NO.       
     Agmatine as a ligand was observed to relax the mesenteric arterioles. These relaxation 
were NO dependent and occurred via α-2 receptor activity. The observed potency of 
agmatine, a metabolite of L-arginine was 40 fold higher than L-arginine itself. This 
suggested us to propose a parallel pathway for L-arginine induced relaxation. Our initial 
finding with salt sensitive hypertensive model showed suppressed L-arginine and 
agmatine activity. We observed an improvement in the blood pressure for agmatine 
treated rats. The observed p values vs. high salt fed rats were 
P value (low salt, high salt) = 0.0304 
P value high salt, high salt + 2mg/ml agmatine) = 0.4232 
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Further investigation is required towards establishing agmatine as a potential anti-
hypertensive agent. In addition, with vascular reactivity study, we identified contribution 
of EDRF, EDHF and receptor mediated activity in salt sensitive hypertension.  
     The vascular properties were identified to be altered in salt sensitive hypertension. We 
developed finite element models that described the biomechanics of rat mesentery. With 
inverse estimation approach we estimated the parameter values that described the 
differences in normotensive and hypertensive Dahl rats. Future work should look into 
integration of subcellular model with the experimental data to describe disease specific 
changes at microvascular level. The integration of subcellular data into computational 
model can allow the analysis of complex microcirculatory function in health and disease, 
hypothesis testing and as a guide for new experimentation.  
     Despite significant efforts and prior work in this area there is an incomplete 
understanding and limited quantitative information of the control mechanisms and effects 
of NO mediated pathway in regulating vascular tone. In this study, we contributed to 
elucidate the significance of NO related mechanisms involved in hypertension by 
designing in-vitro experiments assisted with mathematical models. Our efforts were 
towards guiding current efforts that optimize cardiovascular intervention and to assist 
development of new therapeutic strategies. This work shall prove to be beneficial in 
assisting efficient delivery of NO in the vasculature and minimize the risk while handling 
cardiovascular abnormality such as hypertension.  
*** 
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APPENDICES 
Appendix A1: Vascular Reactivity Protocol 
1.0 Purpose 
This procedure describes the process to dissect, isolate, cannulate and verify the viability 
of the isolated mesenteric artery.  This procedure also verifies if the endothelial cells and 
smooth muscle cells are intact.  
2.0 Materials and Equipment      
1. Cannulation chamber, Living Systems Instrumentation, VT, USA (Model CH1/SH) 
2. Peristaltic pump (Model FC (Living Systems Instrumentation, VT, USA) 
3. Pressure transducer (Model PT/F, Living Systems Instrumentation, VT) 
4. Silicon tubings (Cole Parmer, IL)  
5. Borosilicate glass cannulas (Model GC-12, Living Systems Instrumentation, VT)  
6. Temperature controller (Model TC-01, Living Systems Instrumentation, VT, USA)  
7. Perfusion pencil (8channel/16 channel, Autom8 Scinetific)  
8. Dissecting microscope (Nikon, Model SMZ645, USA).  
9. Motorized Inverted Research Microscope IX-81, USA 
3.0 Reagents 
NaCl, KCl, CaCl2, MgSO4, KH2PO4, HEPES, Glucose, Ach, NE, DI water, NaOH, Ethyl 
alcohol. 
Completed by (Initials/Date) ______________ Verified by (Initials/Date) ____________ 
4.0 Technician Signature Log 
Print Name Signature Initials 
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5.0 Procedure 
5.1 Handling the rat 
5.1.1 Obtain the rat from the animal facility on the day of the experiment. Animal care 
should be taken while transporting the animal. Covered cages accompanied food 
and water supply and carried in air conditioned vehicles.  
5.1.2 Care must be taken to avoid stress to the animal. 
5.1.3 Cages must be transported back to the animal facility within 24 hours.  
5.2 Buffer preparation. 
5.2.1 Modified Krebs Ringer buffer used for the experiment is prepared  
with following salts composition: 
(inmM): NaCl 145, KCl 5, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, HEPES 20, and 
Glucose 10.1. 
5.2.2 The buffer is titrated to pH of 7.4 with 1M NaOH. 
5.2.3 The buffer is maintained ice cold prior to the experiment. 
5.3 Setting up the cannulation chamber, Living Systems Instrumentation, VT, USA (Model 
CH1/SH). 
5.3.1 The cannulation chabmer is thoroughly rinsed and cleaned with DI and 80% ethyl 
alcohol. 
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5.3.2 The vessel chamber allows three dimensional movements of cannulas. The taper 
tip glass cannulas are aligned in the chamber arms using screw and roller 
assembly on the cannulation chamber. 
5.3.3 The chamber was connected with silicon tubings (Cole Parmer, IL) and and used 
borosilicate glass cannulas (Model GC-12, Living Systems Instrumentation, VT) 
with an internal tip diameter of 100-200 microns. The smooth beveled tip 
cannulas allow easy cannulation of the microvessel resulting in minimal damage 
to the endotheium. The smooth beveled tip cannulas allow easy cannulation of the 
microvessel resulting in minimal damage to the endotheium.  Two sutures are 
placed on each canula for tying the vessel on firm on the cannula. 
5.3.4 Control solution is run through the tubings to confirm absence of air bubbles in 
the tubing lines. 
5.3.5 Pressure transducer (Model PT/F, Living Systems Instrumentation, VT) is 
connected to the assembly along with the servo controller (Model PM/4, Living 
Systems Instrumentation, VT (pressure range: 0-200 mmHg)). 
5.3.6 The pressure is maintained at 50 mmHg in closed position. Care is taken to assure 
lack of pressure drop. The entire assembly is maintained air tight. 
5.3.7 Temperature controller (Model TC-01, Living Systems Instrumentation, VT, 
USA) is connected to assure 37C. 
5.3.8 A peristaltic pump (Model FC (Living Systems Instrumentation, VT, USA) is 
used to maintain circulating fluids in the superfusion.  
5.3.9 Driver pressure assembly is regulated with inlet air pressure. The driving pressure 
is adjusted using the pressure knob to maintain pressure drop of 50mmHg. 
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5.3.10 Solenoid valve assembly triggered automatically from the IPLAB or through 
manual valve switching allows instantaneous exchange of solutions. 
5.3.11 The perfusion pencil (8channel/16 channel, Autom8 Scinetific) connected in the 
assembly allows instant switching of solution. The perfusion pencil is pierced in 
the assembly tubing. Care is taken to prevent air leakage. 
5.4 Dissection of rat 
5.4.1 Rats are euthanized in the CO2 chamber by allowing CO2 exposure for 3-5 
minutes. 
5.4.2 Rat is pinched in the leg with a forcep to ensure death. 
5.4.3 Rat is placed on the dissection station, cleaned of abdominal hair and incision is 
made in the abdomen. 
5.4.4 Mesenteric arcade is isolated from the rat abdomen and placed in ice cold buffer 
solution. 
5.4.5 A ring of mesenteric arcade is separated in the pertidish with ice cold control. 
5.4.6 The mesenteric arcade is placed firm with needles. 
5.4.7 Mesenteric arterioles are identified for fat isolation. 
5.5 Fat isolation 
5.5.1 Extensive care is taken while isolating the fat from the arterioles. 
5.5.2 Fat is ‘cut’ using a scissors and forcep under dissecting microscope (Model 
SMZ645). 
5.5.3 ‘Cut’ is very important word no ‘pulling’ or ‘grabbing’ of fat cells. Fat is ‘cut’ in 
the direction away from the arteriole and the vein without touching them. 
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5.5.4 After cleaning the fat, distinction is made between artery and a vein. The thicker 
vessel wall, normally with less blood is the artery. Vein the the inflated, more 
blood filled, thin vessel walled.  
5.5.5 After identifying the distinction between the artery and the vein, the artery is kept 
for the experiment and vein is discarded. 
5.6 Vessel Cannulation 
5.6.1 The buffer in the cannulation chamber and the petri dish is replaced with cold 
buffer solution. 
5.6.2 The cold solution prevents the artery from experiencing shock before while being 
cut. 
5.6.3 The arteriole is cut in the pertidish and carefully lifted and placed in the 
cannulation chamber buffer. 
5.6.4 The both ends of the arterioles are opened and cannulation is carried out one end 
at a time. 
5.6.5 The pressure is lowered to 10 mmHg and blood is allowed to come out of the one 
end cannulated vessel. 
5.6.6 The second end is cannulated and both ends are tied with sutures. 
5.6.7 The vessel is stretched to avoid collapse. Extensive care is taken in the procedure 
to not touch the vessel except for the edge of the vessel. 
5.6.8 After cannulation, the pressure is raised to 50mmHg and is allowed to equilibrate 
for 1 hr. 
5.6.9 The vessel is tested for integrity as described below and vascular reactivity study 
is carried out 
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5.6.10 Images are acquired with an inverted microscope (Motorized Inverted Research 
Microscope IX-81, USA) acquisition protocol and IPLAB software. 
5.6.11 Post analysis is carried out with IPLAB and MATLAB scripting. 
5.7 NE agonist solution for constriction. 
5.7.1 Superfuse cannulation chamber with NE (2µM) agonist solution for 5 minutes 
with a flow rate of 5 mL/min. 
5.7.2 Image vessel with IP Lab software. 
5.7.3 Open program. 
5.7.4 Log in, adjust setting so that they read: Olympus lamp: on, Shutter: on, Camera: 
Bright field. 
5.7.5 Set time to 5 minutes (300 sec.) with one image every 5 seconds. 
5.7.6 Compare diameters of vessel from beginning to end of image capturing.  Vessel 
should constrict by approximately 80%. 
5.8 Ach solution for dilation 
5.8.1 Perfuse vessel with 10 mM Ach for 5 minutes. 
5.8.2 Image with IP Lab software. 
5.8.3 Compare diameters of the vessel from beginning to end of image  captureing.  
Vessel should dilate 90% in diameter.  
Completed by (Initials/Date) ______________ Verified by (Initials/Date) ____________ 
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Appendix A2: FURA-2AM Loading Protocol 
1.0 Purpose 
This procedure describes the process to load endothelial cells of the intact rat mesenteric 
arterioles with FURA 2-AM. 
2.0 Materials and Equipment 
1. Cannulation chamber, Living Systems Instrumentation, VT, USA (Model CH1/SH) 
2. Peristaltic pump (Model FC (Living Systems Instrumentation, VT, USA) 
3. Pressure transducer (Model PT/F, Living Systems Instrumentation, VT) 
4. Silicon tubings (Cole Parmer, IL)  
5. Borosilicate glass cannulas (Model GC-12, Living Systems Instrumentation, VT)  
6. Temperature controller (Model TC-01, Living Systems Instrumentation, VT, USA)  
7. Perfusion pencil (8channel/16 channel, Autom8 Scientific)  
8. Dissecting microscope (Nikon, Model SMZ645, USA).  
9. Motorized Inverted Research Microscope IX-81, USA 
3.0 Reagents 
Fura 2-AM, Pluronic Acid, anhydrous DMSO, Ach, 4Br-A23187, NaCl, KCl, CaCl2, 
MgSO4, KH2PO4, HEPES, Glucose, NE, DI water, NaOH, Ethyl alcohol. 
Completed by (Initials/Date) ______________ Verified by (Initials/Date) ____________ 
4.0 Technician Signature Log 
Print Name Signature Initials 
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5.0 Procedure 
5.1 Preparation of  FURA 2-AM 
5.1.1 All procedures involving dyes were conducted in dark to prevent dye 
autofluorescence. 
5.1.2 Fura 2-AM vial was allowed to reach room temperature before opening the vial. 
5.1.3 50 µL of cell grade anhydrous Dimethyl sulphoxide DMSO at a concentration of 
1 mM.was mixed with 10% solution of Pluronic F127 in DMSO. (DMSO) was 
added to each vial containing 50 µg of fura 2-AM dye. 
5.1.4 Electric mixer was used to dissolve the dye in DMSO. 
5.1.5 The dyes were diluted to 10ml in control solution at room temperature to yield a 
dye concentration of 5 µM for Fura 2-AM and 0.05% Pluronic acid. 
5.2 Loading FURA 2-AM (Endothelial cell loading) 
5.2.1 Solenoid valve operated perfusion system facilitated selective endothelial loading 
after delivery of Fura 2-AM into the lumen for 5 min at 37oC. 
5.2.2 This was followed by a 20 min washout with buffer solution to remove residual 
Fura 2-AM from the lumen. 
5.2.3 The chamber placed on the stage of a fluorescent microscope and cell loading was 
verified visually. After washout endothelial loading was visible on the luminal 
side of the artery in the focal plane.  
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5.2.4 Extra care is taken to prevent the movement of the vessel. This included smaller 
vessel for experiment and vessel placed very near to the cover slip. Such 
precautions greatly enhanced acquisition efficiency. 
5.2.5 The changes in intracellular Ca2+ is observed by calculating the ratio of the light 
emitted through a 510 nm emission filter when the vessel was illuminated at 340 
and 380 nm respectively. 
5.3 Loading FURA 2-AM (Smooth Muscle cell loading) 
5.3.1 Smooth Muscle loading can be achieved by following identical protocol by 
delivery of Fura 2-AM into the lumen for 20-30 min at 37oC. 
5.4 Fluorescent Imaging 
5.4.1 The arteriole was observed under UV light at 10X magnification. 
5.4.2 The data was collected at 200 millisecond exposure time with 2x2 binning for 
excitation of Fura 2 loaded cells at both 340 and 380 nm.  
5.4.3 Exposure time was varied depending upon the extent of dye loading but the 
proportions of individual exposure times were maintained. Preliminary studies 
examined the effect of changing the exposure time. Important imaging criterions 
like binning, camera gain, filter switch speed, and shutter wait time were 
determined empirically and maintained during all experiments. The parameters 
ensure optimum range of data collection, minimum vessel damage due to 
exposure, prevention of dye oversaturation and minimization of motion artifacts 
resulting from drift in focus. 
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Appendix A3: Microscopy 
Nikon dissection microscope (Model SMZ645) was employed for microdissection 
i.e. removal of fat from the mesenteric microvessel and identifying artery from vein. The 
same microscope was also employed for adjusting the two cannulas at the same level, 
cannulating the microarteries and suturing the microarteries to the glass cannulas. 
Olympus fluorescent microscope (Motorized Inverted Research Microscope IX-81, USA) 
was used in bright field mode. The microscope components critical for bright field 
experiments were: 
Olympus shutter, Olympus lamp and Camera 
Olympus shutter was used to control exposure time of the light from Olympus 
lamp (IX-2 UCB) onto the vessel. The exposure time was set so that the vessel can be 
seen clearly on the screen and hence the diameter measurements can be performed using 
the IPLab4.0 software.The Olympus lamp (IX-2 UCB) was used to provide visible light 
to the vessel. The intensity of the light was controlled manually from the microscope or 
from the software IPLab4.0. Cooled mono 12 bit Retiga Q imaging camera (Model 
EXi)is employed for image acquisition. The camera was operated at a gain of 1557 and 
an offset of 2048. The gain and offset for the camera were maintained to acquire 
consistent and comparable results. 
Objective 
Objective with magnification of 4X bright field and 10X in fluorescent 
observation was used to record images for this study. The objectives have to be focused 
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to get a clear picture of the vessel. The focusing is done manually using the microscope. 
The various specifications of the used objective are 
Magnification Numerical Aperture Working distance (mm) Depth of field 
4X 0.16 8.2 55.5 
 
Table 1: Important objective (4X) characteristics 
IPLab 4 for Windows 
Software IPLab 4.0 Windows version (Scanalytics, VA, USA) was used to control 
the microscope and the associated hardware. IPLab 4.0 allows control of shutter, filter 
wheel, camera and objectives. The diameter measurements were recorded with the help 
of the software manually as well as with the script for measuring diameter in bright field 
mode. 
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Appendix A5: Dahl Salt Sensitive Hypertension Protocol 
1. Animal model 
In 1962 Lewis Dahl developed the Dahl Salt-Sensitive (S) and Salt-Resistant (R) rat 
strains from Sprague Dawley rats which were bred on the basis of their blood pressures 
after being fed a high salt (8% NaCl) diet2,3. These strains developed by Dr. Dahl were 
designated as the Dahl Salt- Sensitive (S) and Salt-Resistant (R) Brookhaven outbred 
strain. The inbred strain of Dahl Salt Sensitive and Dahl Resistant rats were developed in 
1985 by John Rapp from these Brookhaven rats5. They are designated as Dahl/SS/Jr. The 
Dahl salt sensitive rat is a rodent model of hypertension that exhibits many phenotypic 
traits common with hypertensive disease observed in human populations. Similarities 
include sodium sensitivity of hypertension, reduced renal function, elevated urinary 
excretion of protein and albumin, and a low plasma renin activity. Tubulointerstitial 
injury and the loss of Nitric Oxide Synthase (NOS) occur after birth and parallel the 
development of hypertension. It is suggested that the structural and functional changes 
that occur with renal injury in the Dahl/SS rat may contribute to the development of 
hypertension. 
It has been demonstrated that the development of hypertension is accentuated in genetic 
models of hypertension depending on the diet being fed and it has been recommended 
that a AIN-76A diet with 4-8% salt works well in producing hypertension and kidney 
disease in a timely manner in the Dahl/SS rat. Additionally Mattson, et al, have shown 
that the source of protein, carbohydrate, fat, and/or other dietary components can have a 
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significant impact on the disease produced in experimental models of hypertension and 
renal disease.  
The Dahl/SS rat has a low renin salt sensitive form of hypertension. It is associated with 
declining renal function. 
2. Ordering the Animals and Diet:  
ANIMALS:  
The following vendor can be contacted for ordering the Dahl sensitive and the Dahl salt 
resistant rats: 
Vendor 1: Harlan Teklad 
http://www.harlan.com/contact_us/contact_us__North_America.hl 
Call: 800-793-7287 
3 – 4 weeks old SS/JrHsd rats 
Price: $ 64.90 each 
Shipping  handling: $42.00 
Vendor 2: Charles River 
http://www.criver.com/en-US/Pages/home.aspx 
Call to order: Charles River # 1-800-522-7287 
Pricing as of 1st Dec 09  
Salt Sensitive: $63.20 for one piece 
Salt Resistant (SS-13BN) control rat: $63.20 for one piece 
Housing: $13.30 
Shipping: $27.15 
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DIET: 
Vendor 1: Harlan Teklad 
http://www.harlan.com/contact_us/contact_us__North_America.hl 
Call: 800-483-5523 
Formula  
TD.90228        SodiumDeficientDiet 
TD.96208        0.49%NaClDiet 
TD.90229        1%NaClDiet 
TD.92034        4%NaClDiet 
TD.92012                8% NaCl Diet 
Vendor 2: Research Diets 
The following vendors can be contacted for ordering the diet  
www.ResearchDiets.com 
Call to order: Research Diet # 732-247-2390 
D10001 (AIN-76A): price $ 362.5 (50 Ibs)  
D05011703:  Modified AIN-76A diet containing 4% added sodium chloride  
1. American Institute of Nutrition. AIN report of the AIN ad hoc committee on standards 
for nutritional studies.J.Nutr. 107:1340-1348, 1977.  
2. American Institute of Nutrition. AIN second report of the AIN ad hoc committee on 
standards for nutritional studies. J. Nutr. 110:1726, 1980.  
3. Housing and Feeding Requirement for Rats 
• In addition to the regular 5 Male Sprague Dwaley rats that we normally order, we require 
additional space for 8 Dahl salt sensitive rats.  
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• The rats are allowed initial acclimatization period for the to get adjusted to the new 
environment, these rats are maintained on diet standard diet. 
• After an initial acclimatization for the rats to get adjusted to the new environment, At age 
of 42 days old, We separate the rats in two groups, the control rats are required to be fed 
the low salt TD.96208(0.5% NaCl) diet and the other 2 dahl salt sensitive, SS/JrHsd to be 
fed the TD.92034 (4% NaCl, High Salt) diet for 5 weeks. It should take 4-6 weeks for 
these rats to develop hypertension.  
• We have to monitor the blood pressure during these 6 weeks (Ideally 1-2 times a week). 
The CODA system as described later shall be used to monitor the blood pressure. We are 
required to have a space for the measurement of blood pressure of the animals at the 
animal facility. A student from our lab shall be responsible for taking the blood pressure 
measurements.  
• Starting from the beginning of  week 6: we shall do one experiment per week sacrificing 
two rats at a time.  
• At week 6: we thus sacrifice 2 high salt diet rats 
• At the beginning of Week 5, we shall repeat the order cycle of 8 animals in two stages 
over four week period once again. Thus every two weeks henceforth we shall be ordering 
4 animals and sacrificing 4 animals. 
• Hence at the animal care facility, we require space for a maximum of 8 male Dahl salt 
sensitive SS/JrHsd rats in addition to the regular 5 outbread male Sprague Dwaley rats 
that we order at present. Thus we require a housing space for a maximum of 13 animals. 
In addition to this we as well require some space for the blood pressure system to record 
the blood pressure from these animals.  
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4. Monitoring the blood pressure Tail Cuff method: 
Non-Invasive Blood Pressure Measurement:  
The non-invasive blood pressure methodology consists of utilizing a tail-cuff placed on 
the tail to occlude the blood flow. Upon deflation, one of several types of non-invasive 
blood pressure sensors, placed distal to the occlusion cuff, can be utilized to monitor the 
blood pressure. There are three types of non-invasive blood pressure sensor technologies: 
photoplethysmography, piezoplethysmography and Volume Pressure Recording. Each 
method will utilize an occlusion tail-cuff as part of the procedure. 
Volume Pressure Recording (VPR): 
The Volume Pressure Recording sensor utilizes a specially designed differential pressure 
transducer to non-invasively measure the blood volume in the tail. Volume Pressure 
Recording will actually measure six blood pressure parameters simultaneously: systolic 
blood pressure, diastolic blood pressure, mean blood pressure, heart pulse rate, tail blood 
volume and tail blood flow.  
Since Volume Pressure Recording utilizes a volumetric method to measure the blood 
flow and blood volume in the tail, there are no measurement artifacts related to ambient 
light; movement artifact is also greatly reduced. In addition, Volume Pressure Recording 
is not dependent on the animal’s skin pigmentation. Dark-skinned animals have no 
negative effect on Volume Pressure Recording measurements. Very small, 10-gram 
C57/BL6 black mice are easily measured by the Volume Pressure Recording method. 
Special attention is afforded to the length of the occlusion cuff with Volume Pressure 
Recording in order to derive the most accurate blood pressure readings. 
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Volume Pressure Recording is the most reliable, consistent and accurate method to non-
invasively measure the blood pressure in mice as small as 10 grams to rats greater than 
950 grams. 
Rodent Holders 
• The ideal animal holder should comfortably restrain the animal, create a low-stress 
environment and allow the researcher to constantly observe the animal’s behavior.  
• A trained rat or mouse should comfortably and quietly remain in the holder for several 
hours. 
• It is very beneficial to incorporate a darkened nose cone into the rodent holder to limit the 
animal’s view and reduce the level of animal stress. The animal’s nose will protrude 
through the front of the nose cone allowing for comfortable breathing.  
• The tail of the animal should be fully extended and exit through the rear hatch opening of 
the holder. 
• The proper size animal holder is essential for proper blood pressure measurements. If the 
holder is too small for the animal, the limited lateral space will not allow the animal to 
breathe in a relaxed fashion. The animal will compensate by elongating its body, thereby 
creating a breathing artifact. A breathing artifact will cause excessive tail motion and 
undesirable blood pressure readings. 
Animal Body Temperature 
• A non-invasive blood pressure system should be designed to comfortably warm the 
animal, reduce the animal’s stress and enhance blood flow to the tail. 
• The rodent’s core body temperature is very important for accurate and consistent blood 
pressure measurements. The animal must have adequate blood flow in the tail to acquire 
111 
 
a blood pressure signal. Thermo-regulation is the method by which the animal reduces its 
core body temperature, dissipates heat through its tail and generates tail blood flow. 
• Anesthetized animals may have a lower body temperature than awake animals so 
additional care must be administered to maintain the animal’s proper core body 
temperature. An infrared warming blanket or a re-circulating water pump with a warm 
water blanket is the preferred method to maintain the animal’s proper core body 
temperature. The animal should be warm and comfortable but never hot. Extreme care 
must be exercised to never overheat the animal. 
• Warming devices such as hot air heating chambers, heat lamps or heating platforms that 
apply direct heat to the animal’s feet are not advisable to maintain the animal’s core body 
temperature. These heating devices will overheat the animal and increase the animal’s 
respiratory rate, thereby increasing the animal’s stress level. These conditions will elicit 
poor thermo-regulatory responses and create inconsistent and inaccurate blood pressure 
readings. 
• The animal body temperature is generally maintained at 32-35C 
Environmental Temperature 
• The proper room temperature is essential for accurate blood pressure measurements. The 
room temperature should be at or above 26°C. If the room temperature is too cool, such 
as below 22°C, the animal may not thermo-regulate, tail blood flow will be reduced and it 
may be difficult to obtain blood pressure signals. A cold steel table or a nearby air 
conditioning duct is undesirable during animal testing. 
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Animal Preparation for blood pressure measurement: 
The animal should be placed in the holder at least 10 to 15 minutes prior to obtaining 
pressure measurements. Acclimated animals will provide faster BP measurements than 
non-acclimated animals. Proper animal handling is critical to consistent and accurate 
blood pressure measurements. A nervous, stressed animal may have diminished 
circulation in the tail. 
Most rodents will quickly adapt to new conditions and feel comfortable in small, dark 
and confined spaces. Training is not necessary to obtain accurate blood pressure readings; 
however, some researchers prefer training sessions. Rodents can easily be trained in 
approximately three days, 15-minutes each day before beginning your experiment. 
The animal should be allowed to enter the holder freely. After the animal is in the holder, 
adjust the nose cone so the animal is comfortable but not able to move excessively. The 
animal should never have its head bent sideways or its body compressed against the back 
hatch. The animal’s temperature should be monitored throughout the experiment. 
Measuring blood pressure using Volume-Pressure Recording (tail cuff method): 
CODA non invasive blood pressure system enables the blood pressure measurements in 
rodents with the volume sensor recording that measure the tail volume blood changes 
when placed over the animal’s tail.  
1. Set up system: 
• Use locations where the temperature is 20C or above avoid the locations near vibrations, 
freezers or air conditioning vents. Exposing the animals to loud noise or odors may stress 
the animals.  
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• Turn on the CODA Controller and then the warming platform to level 3. If the room 
temperature is above 25C start at level 1 or 2. 
• Perform the controller diagnostics test,  
• First open the CODA software, Select the CODA device by clicking on it.  
• Click on Test Selected Device 
• Select the cuffs and channels to test and click test 
• After the controller diagnostic is complete close the diagnostic test window 
• Select the CODA controller to use then click use these devices 
• To setup the software Select ToolsManage Personnel 
• Next click on Researcher1 to Change the name to say Tushar 
• Click on subsequent rows to add additional researchers 
• Then click Save Data 
• Click on the specimens tab to name the animal for easy identification or animal type and 
click Save 
• Finally click on animal tab to select the animal type and sensitivity save data close. 
• To begin a new experiment Select FileNewExperiment 
• Give the experiment name, select the key researcher and select the begin date and click 
next 
• The next step is to enter the basic session information. Start by entering the session name.  
• Set acclimation cycles to 5 if you prefer not to include acclimation cycles set it to 0. 
• Set the number of sets to 1, Time between sets to 30 secs for multiple sets, cycles per set 
to 20 cycles, and time between cycles to 5 secs then click next 
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• To begin specimen selection select specimen from the specimen pool and assign it to the 
first available channel and click next 
• To set session parameters, set the maximum occlusion pressure to 250 mmHg, deflation 
time to 20 sec per rat, minimum volume to 15 µlitres, select the display style to one 
channel per graph. Click next 
• Review the session script and click next DO NOT CLICK FINISH until you finish the 
animal preparation section which is described next. 
2.  Prepare the animals 
• Before placing the animals in the holders, make sure that the size of the animal is such 
that it will be freely be able to enter the holder.  
• Place each animal in the holder by picking it up by the tail and gently placing it in the 
rear of the holder which faces the open end of the nose cone. Carefully secure the rear 
hatch to the holder by turning the screw on the rear hatch. Be careful not to pinch the tail 
or other body parts while securing the hatch.  
• Slide the nose cone to the hatch limiting the movement of the animal. The nose cone 
should be in a position to limit the animal from turning around while in the holder.  
• Place the holder on the warming platform in the designated position. Allow the animal 
atleast 5 min to acclimatize to the holder.  
• DO NOT TOUCH the animals while inside the holder. The increase contact could irritate 
the animal. NEVER leave the animal in the holder unattended.  
• To properly place the occlusion tail cuff, thread the tail through the occlusion cuff and 
place the tail-cuff as close to the base of the tail as possible without force. After that 
thread the tail through the BPR sensor cuff; placing it within 2 mm of the occlusion cuff. 
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Secure the tubing and the occlusion cuff to the top rear of the holder. The occlusion tail 
cuff is inflated to impede the blood flow to the tail. The occlusion cuff is slowly deflated 
and the VPR tail cuff incorporating the specially designed sensor measures the 
physiological characteristics of the returning blood flow. As the blood returns to the tail 
the VPR sensor cuff measures the tail swelling as a result of the arterial pulsation from 
the blood flow. 
• Systolic BP is automatically measured at the first appearance of the tail swelling, 
Diastolic BP is calculated when the increasing rate of swelling seizes in the tail.  
• After all the animals are placed in the holders and their tails have been cuffed allow 
atleast 5 mins for the animals to thermo-regulate. Record the temperature frequently with 
the infrared thermometer. The animal temperature should be between 32-35C. 
3. Data Collection and Processing: 
• Now that the animals are ready, we can begin the experiment. Click FINISH to begin the 
experiment.  
• The RED line indicates the deflation of the VPR sensor and the occlusion cuff. BLUE 
line represents the blood volume changes in the tail. The first deflection of the blue line 
minimum rate of change identifies the systolic blood pressure. The second inflection of 
the blue line the maximum rate of change identifies the diastolic blood pressure.  
• When the experiment has ended remove the animals immediately from the cuffs and 
holders.  
• A simple session summary report is displayed. The data collected in the experiment is 
saved as an excel file. There are several ways to process the data in the excel file. A 
common practice is to obtain the average and the standard deviation. Delete 
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measurements if the standard measurement is greater than 30. Additionally the rejected 
cycles may be viewed and the entire data can be exported to exel. 
• Consult the User manual and the demonstration video on the following for more 
information: 
• http://www.kentscientific.com/ 
Use the following text when referencing the CODA system in your research:  
Blood pressure was non-invasively measured by determining the tail blood volume with a 
volume pressure recording sensor and an occlusion tail-cuff (CODA System, Kent 
Scientific, Torrington, CT)  
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Appendix A5: Real Time PCR Protocol 
Homogenization 
1. Remove RNA later from tube containing tissue (≤30 mg). 
2. Add 600 μl of RLT buffer. 
3. Homogenize using a sonicator (10 sec  x  5  at 9 watts). Always rinse probe with 
chloroform first. 
4. Centrifuge the lysate for 3 min at full speed. 
5. Use supernant for RNA isolation. 
RNA Isolation Protocol 
1. Add 1 volume of 70% ethanol to the homogenized lysate and mix well by pipetting.  
2. Transfer about 700 µl of each sample to RNeasy spin column and centrifuge at 10,000 g 
for 30 sec. 
3. Add 700 µl Buffer RW1 to each column and spin at 10,000 g for 20 sec.  
• For the next step use a new collecting tube. 
4. Add 500 µl Buffer RPE to each column and spin at 10,000 g for 20 sec. 
5. Add another 500 µl Buffer RPE to each column and this time spin at max speed for 2 
min.  
• Critical step! Make sure to remove all ethanol collected over the inner rim using a 
pipette tip, without touching the membrane.   
6. Dry spin at max speed for another 5 min.  Remove ethanol again.  
• Begin setting vacuum centrifuge for Step 10 
7. Place the column in a new 1.5 ml collection tube. 
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8. Add 40 µl RNase-free water at the center of membrane in column and let it sit for 1 min. 
Spin at max speed for 1 min.  
9. Add another 40 µl water and spin again after 1 min incubation. 
• Steps 8 and 9 are Elution steps 
10. Discard the filter unit, keep tube and spin the tube alone in a vacuum centrifuge at 55 °C 
for 2 min to eliminate traces of leftover EtOH. 
DNA digestion of RNA sample: 
1. Mix the following in a microcentrifuge tube: 
• 70 µl RNA sample + 10 µl Buffer RDD + 2.5 µl DNase I stock + 17.5 µl RNase free 
water = 100 µl. 
2. Spin briefly and let sit at RT for 12 min. 
3. Add 350 µl of RLT buffer  
4. Add 450 µl of 70% ethanol to the above 
Repeat RNA Isolation protocol to purify RNA. 
Then take spectrophotometer readings for mRNA concentration. 
1. Test for RNA/DNA quality:  
• In control use 150 µl RNase-free water 
• 3 µl sample + 147 µl H2O for sample reading  
2. This reading should be 1.8-2.0 for a fairly pure RNA sample. 
First Strand cDNA synthesis by Superscript III RT 
1. Up to 5 µg of RNA in 0.5 ml PCR tubes with 3 simultaneous reactions 
RNA    up to 5 µg 
Random Hexamers  3 µl 
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dNTP    3µl 
H2O    for a total of 13 µl 
2. Incubate at 65˚C for 5 minutes. 
3. Place on ice for 1 minute and spin briefly to collect sample. 
4. In a 0.5 mL tubemix well the following: 
10 x RT Buffer  6 µl 
MgCl    12 µl 
DTT    6 µl 
RNaseOUT   3 µl 
SuperScript IIIRT   3 µl 
Total    30 µl 
5. Add RNA mix   30 µl 
6. Mix gently and collect by brief spin. 
7. Transfer Tubes to thermocycler with settings: 
25°C, 10 minutes 
50°C, 50 minutes 
85°C, 5 minutes 
8. Take tubes out and chill on ice. 
9. Collect the reactions by a brief spin 
10. Add 3 µl RNase H to each tube and incubate for 20 minutes AT 37°C in thermocycler. 
cDNA Purification 
1. Take 1 volume of cDNA sample and add 5 volumes of buffer PB 
2. Pass through a column 750 µl each time. Spin at more than 10 000 rpm for 30 seconds 
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3. Wash with 750 µl of PE. Spin at less than 10 000 rpm for 30 seconds 
4. Pipette out liquid from within the column  
5. Dry spin for 10 minutes at 13.3 K and room temperature   
6. Transfer column to a 1.5 ml micro fuge tube  
7. Add 30 µl of RNase free water, let it sit for 1 min, then spin at 13.3 K for 1 minute at 
room temperature. 
8. Repeat step 7 two more times. 
9. Place sample on ice while taking the spectrophotometer readings. 
RT-PCR Protocol 
Materials Required 
 Milli-Q water autoclaved 
 Primers (Forward and Reverse) 
 Master Mix 
 cDNA 
 1.5 ml Eppendorf  tubes 
 0.5 ml Eppendorf tubes  
 RT-PCR tubes 
Procedure 
1. Spin primers in centrifuge for 30 seconds before diluting them.  
a. Note: Use Milli-Q water autoclaved to dilute the primers 
2. Add the necessary amount of water to each primer to obtain the necessary 100 µmol 
concentration. 
3. Vortex them until mixed thoroughly  
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4. Add 12.5 µl of each primer and add 237.5 µl of milli-Q water (to prepare a 5 µmol 
working stock) 
5. General ratio for the preparation 
Components Ratio for 1x reaction (µl) 
2x MM 10 
cDNA 10 ng 
Forward Primer (FP) 1 
Reverse Primer (RP) 1 
H2O Add for a total of 20 
Total 20 
 
6. Due to the specifications of the RT-PCR machine, 60 µl of the above mixture are needed 
to run each test consisting in 3 wells. It is advisable not to prepare exactly 60 µl just in 
case the pipettes are not exact enough. 70 µl are usually prepared to overcome this 
problem.  
Components Ratio for 3.5x reaction (µl) 
2x MM 35 
cDNA 30 ng 
Forward Primer (FP) 3.5 
Reverse Primer (RP) 3.5 
H2O Add for total of 70 
Total 70 
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7. In order to reduce the use of pipettes and thus the measurement error, prepare an initial 
mixture with the necessary amount of Master Mix, cDNA and water. Vortex mix by 
hand, then place in centrifuge for 30 seconds. 
8. Separate into 3 aliquots and add 3.5 µl of forward primer and reverse primer to each 
aliquot. The volume in each Eppendorf tube should now be 70 µl.  
9. Centrifuge for 30 seconds at less than 700 rpm 
10. Add 20 µl aliquots to the PCR tubes 
a. Note: **Crucial Step** 
i. When extracting the 20 µl, push solution in out of pipette tip until no bubbles arise from 
this procedure.  
ii. When transferring the 20 µl into the PCR tubes make sure that the pipette is maintained 
pressed between each transfer to ensure that there is a small or no difference in the 
volumes of each well.  
11. Spin the wells in the centrifuge <2500 rpm for about 2 minutes. Make sure that no 
residue is left on the walls of the tubes.  
12. Run the RT-PCR machine.  
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Appendix A6: Biomechanics Principles 
The arterioles are assumed to be a thin walled hyperelastic cylinder in 2D deformed in 
circumferential θ and axial z direction.  
For a cylindrical vessel under inflation and axial stretching  
1. For a cylindrical vessel under inflation and axial stretching, the equilibrium equation is  
0=
−
+
rdr
d rrrr θθσσσ  
From this equation and the boundary condition that the pressure at the outer surface is 
zero, the internal pressure is given as  
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whereriand r0 are the inner and outer radius respectively. 
2.  The Green strain is defined as: 
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where 0/ DD=θλ  and 0/ LLz =λ  are the circumferential and axial stretch ratio and D 
and D0 are the loaded and zero stress diameter; and L and L0 are the axial lengths in 
loaded and no load state.  
Assuming uniform density of vessel wall loaded and zero stress state; the First-
PiolaKirchoff and Cauchy stress can be written as: 
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and 
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S
2
2
λσ
λσ θθθθθ
=
=
 
Where θθS and zzS are the circumferential and axial second Piola-Kirchoff stresses 
respectively. 
3. The relationship between stress strain  
E
WS
∂
∂
=  
where 
S – the second Piola-Kirchhoff stress tensor 
E – Green-Lagrange strain tensor  
W – strain energy density function 
4. Energy function of soft biological tissues (Fung 1979) 
Where the work function is given by 
( )
.
2
1
,1
2
1
MNKLKLMN
Q
EEaQ
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Where  
( ) ( )
( ),
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c1- c9: parameters of the strain energy function (Fung 1979)  
Number of parameters – material 
1 (2) – isotropic, incompressible, linear (nonlinear)  
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2 (3) – isotropic, compressible, linear (nonlinear) 
9 (10) – orthotropic, compressible, linear (nonlinear) 
For the constitutive relation to be used in a computational model, the convexity of strain 
energy function has to be satisfied to ensure the stability of loading. The strain energy W 
should be positive definite. To ensure this condition, the eigen values of the matrix  
C = ,
332313
232212
131211




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

ccc
ccc
ccc
 
have to be positive, the condition is equivalent to following the three equations 
( ) ( ) ( ) .0.3
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